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INTRODUCTION 
 The siddha system of medicine has been practicing in our country since 
time unknown.  The basic emphasis of siddha system is on positive health viz., 
to prevent disease by careful dieting and proper control of the mind to achieve 
a good health that assures not only longevity but also immortality. 
 The siddha system of medicine is a gift to mankind given by the 
Siddhars.  It is the speciality of siddha system and its non-differntiation of food 
and medicine. 
"cznt kUªJ kUªnj czî" 
 In siddha system diseases are initially treated with herbal preparations 
and then by metals, minerals and Jeeva vaguppu etc., to cure diseases. 
"nt®ghU jiHghU ÄŠád¡fhš bkšybkšy 
g‰g brªöu« ghnu" 
Siddha system has its own developed chemistry and the siddhars training in the 
direction of its development had resulted in the genesis of thousands of 
minerals and metallic preparations, thus the system is well equiped to compact 
any type of diseases. 
 The materia medica of the siddha system is the outcome bulk of 
siddhar's therapeutic wisdom.  These medicines in the form of decoction, 
powders, pills, oils, parpam, chenduram and external medicines will offer cure 
for any kind of diseases. 
 The people are needed to have easily available medicines to cure many 
diseases.  Nature has given us a wide variety of medicinal plants to preserve 
good health and cure diseases.  The siddha system is dealing with natural 
system of medicines with very least adverse effects.  So, the siddha system of 
medicine is living science for ever. 
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 Siddha system of medicine is one of the most important Indian system 
of medicine. Nowadays the Indian system of medicine is undergoing 
revolutionary changes. 
 Nowadays physicians have started prescribing indigenous medicines for 
liver diseases, gynecological problems, cancer, HIV, Diabetes, Calculus, 
Haemorrhoids etc., for their known least side effects. 
 Most of the chronic diseases are caused by the derangement of vatha 
humour.  Among them, vali azhal keelvayu (Rheumatoid Arthritis (RA)) 
disease classified under the vatha diseases. 
 Vali Azhal Keelvayu is the most common inflammatory arthritis in 
women, affecting small and large joints.  Before the age group of 45, the 
female : male incident ratio is 6:1, prevalence increases with age with 5% of 
women and 2% of men over 55 years being affected.  The clinical course is 
usually life long with intermittent exacerbations and remissions and highly 
variable severity.  So the medicines should be taken for life time, which should 
be effective, non toxic and safe. 
 A part of my dissertation work, I have chosen MUDAKKATRAN 
CHOORANAM obtained from Mudakkatran whole plant (including the root) 
given for 'VALI AZHAL KEEL VAYU' (Rheumatoid arthritis). 
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AIM AND OBJECTIVE 
 
 The ultimate aim of the disssertation work is to prove the efficacy of 
Mudakkatran Chooranam to treat Vali Azahal Keelvayu (Rheumatoid 
Arthritis).  
 Mudakkatran is a well known drug for vatha diseases.  In Siddha 
literature Mudakkatran is also mentioned for skin diseases and ear ache. 
 Vali Azhal Keelvayu is an autoimmune disease, which affects the joints 
of millions of people each year.  Patient with auto immune diseases have 
antiboidies in their blood that target their own body tissues, associated with 
inflammation.  It also affects other organs of the body.  
 The prevalance of Vali Azhal Keelvayu is approximiately 1% of the 
population.  Women are affected approximately three times more often than 
men.  The onset of the disease is most frequent during the fourth and fifth 
decades of life with 80% of all patients developing the disease between the 
ages of 35 and 50.  Many chronic diseases including Vali Azhal Keelvayu 
considered incurable in other systems of medicine can be treated successfully 
with siddha medicines.  
 I have slected this herbal drug which may be very suitable to treat Vali 
Azhal Keelvayu naturally without any side effects.     
 The main objective of this present study is to create an awareness about 
the Siddha Science and to highlight the efficiency of siddha drug among the 
public.  With the basic intention in mind following specific objectives have 
been drawn. 
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1. My aim is to gather all the information about the trial drug 
Mudakkatran and its therapeutic use for Vali Azhal Keelvayu. 
2. Pharmacognostic study 
3. Bio-Chemical analysis 
4. Microbiological study 
5. Pharmacological study 
6. Clinical study 
7. Bio - Statistical study. 
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REVIEW OF LITERATURE 
I. GUNAPADAM ASPECT51 
Kl¡f‰wh‹ (MUDAKKATRAN) 
Botanical Name : Cardiospermum halicacabum Linn. 
ntWbga®fŸ: 
 Kl¡bfh¤jh‹ ng®jidna bkhÊa¡ nfS 
  KÅthd u¤jghâ ahîkhF« 
 gl¡bfh¤jh‹ ghÕnuh¤jh ÉRtbfªâ 
  gh§fhd »Çth¤âa« m§fghâ 
 kl¡bfh¤jh‹ k©lyfh ufKkhF 
  kf¤jhd m§fgâ ójdhF« 
 Él¡bfh¤jh‹ Éõmªâu thjdhá 
  És«ãa njh® Kl¡bfh¤jh‹ Égukhnk50 
 
bghUŸ:  Kl®F‰wh‹, Kl¡fW¤jh‹, u¤jghâ, gl¡bfh¤jh‹, 
ÉRtbfªâ, »Çth¤âa«, m§fghâ, kl¡bfh¤jh‹, 
k©lYfhuf«, m§fgâój‹,  Éõmªâuthj‹. 
ga‹gL« cW¥ò :  ïiy, nt® 
Fz« : Rit   - Jt®¥ò 
  j‹ik - bt¥g« 
  ãÇî - fh®¥ò 
brŒiffŸ:1, 51 
 áWÚ® bgU¡» - Diuretic 
 kyÄs¡» - Laxative 
 gá¤Ôö©o - Stomachic 
 clš nj‰¿ - Alterative 
 jo¥ò©lh¡» - Rubefacient 
 thjkl¡» - Antivatha 
 Éa®it bgU¡» - Diaphoretic 
 thªâí©lh¡» - Emetic 
 NjfK©lh¡» - Emmenagogue 
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bghJFz« :51 
 Niy ão¥ò brhÇ áu§F t‹fu¥gh‹ 
 fhiy¤ bjhLthŒî§ f‹kyKŠ-rhy¡ 
 fl¡f¤jh ndhoÉL§ fháÅia É£L 
 Kl¡f‰wh‹ w‹id bkhÊ   (mf¤âa® Fzthfl«) 
bghÊ¥òiu : 
 Ñšão¥ò, áid¥ò, »uªâ, fu¥gh‹, ghj¤ij mDrÇ¤j 
thj«,  ky¡f£L KjÈa nehŒfŸ Kl¡f‰whdhš ÔU«. 
tH¡F KiwfŸ : 
• ïiy, nt® KjÈat‰iw FoÚÇ£L, tË, _y«, eh£g£l 
ïUkš KjÈaitfS¡F bfhL¡fyh«. 
• ïiy¥bghoíl‹ á¤âu_y nt®g£il bgho, fÇanghs« ïit 
nr®¤J _‹WehŸ ju Njf f£L Ú§F«. 
• ïiyfis tj¡» motÆ‰¿š f£l Njf¤ij ÄFâ¥gL¤â 
Nyf mG¡Ffis btË¥gL¤J«. 
• ïiyia v©bzÆÈ£L fhŒ¢á, m›bt©izÆid 
tÈfS¡F óryh«. 
• ïiy¢rh‰iw¡ fhâš Él fhJtÈ, Óœtojš Ú§F«. 
• nt® FoÚiu _ynehŒ¡F¤ juyh«. 
• Kl¡f‰wh‹ bfhoÆ‹ FoÚUl‹ Mkz¡bf©bzŒ T£o¤ ju 
ky« fÊí«. 
Kl¡f‰wh‹ nrU« kUªJfŸ  
1.  thjehr ijy«17 
• beh¢á, Kl¡f‰wh‹, åÊ, bt©rhuiz, c¤jhkÂ, ght£il, 
bghLjiy - ïitfË‹ rhWfŸ jyh 1/4 go 
• nj§fhŒ ghš, á‰whkz¡F beŒ - tif¡F 1/4 go 
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• ïâš R¡F, tr«ò, Óuf«, njtjhU, f¥ò kŠrŸ, fÞöÇ kŠrŸ, 
btŸis¥ ó©L, c¤jhkÂ nt®, bgU§fha«, ÄsF, R£l 
Mik xL - tif¡F 1 thuf‹. 
• ru¡Ffis nj§fhŒ ghš É£liu¤J fy¡» mL¥ng‰¿ áW Ôahf 
vÇ¤J gjKw ijy§fhŒ¢á to¤J¡bfhŸs nt©L«. 
msî :  1/2 - 1 gy«, fhiyÆš k£L«, 3 eh£fŸ 
ÔU« nehŒfŸ : 
 thjnehŒfŸ, iffhš ão¥ò, Fil¢rš, ïL¥ò tÈ, Ñšthí, 
XL thí. 
2.  Klf‰wh‹ v©bzŒ17 
 Kl¡f‰wh‹ rhW  - 1/2 go 
 fŸË rhW    - 1/2 go 
 á‰whkz¡bf©bzŒ - 1 go 
ïitfis¡ fyªJ xU ijy gh©l¤âÈ£L, mâš á¤âu _y 
nt®g£il, bt©fh¡f£lh‹ nt®, á‰wu¤ij, ïªJ¥ò, bgU§fha«, 
fH‰á nt® g£il, fH‰á É¤J tif¡F 1/2 gy«, btŸis ó©L 1 1/2 
gy«, vL¤J miu¤J nr®¤J fyªJ mL¥ng‰¿ áWÔahf vÇ¤J gjkhf 
fhŒ¢á to¤J¡ bfhŸsî«. 
msî :  1/4 - 1/2 mî‹Þ, fhiy k£L«, 2-3 eh£fŸ (fL«g¤âa«) 
ÔU« ãÂfŸ :  m©lthj«, Flš thj«, thjNiy 
3.  Kl¡f‰wh‹ rhW - 1/2 go 
ešby©bzŒ - 1/2 go 
tr«ò, ó©L, bgU§fha«, âÇfLF, ïªJ¥ò, Óuf«, rjF¥ig, 
gw§»g£il, njtjhu« tif¡F 1 fHŠR miu¤J És¡bf©bzÆš 
ngh£L¥ gjkhŒ fhŒ¢á vL¤J¡bfhŸs nt©L«. 
msî :  xU fhrsî 
ÔU« ãÂ :  Njfthí16 
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4.  FHªijfË‹ br§»uªâ¡F kUªJ16 
  _¡fiu¢rhuiz, Kl¡f‰wh‹, br¥ò beUŠáš, 
K¤bjU¡fŠbrÉ, xÇjœ jhkiu, bt§fha«, kÆÈwF, ïitbašyh« 
xnu rkkhŒ j£o vL¤J¡ bfh©L á‰whkz¡F v©bzÆš ngh£L 
fhŒ¢á FHªijf¡F cŸS¡F bfhL¤J jhŒ¡F nkny ór br§»uªâ 
ÔU«. 
5.   fH‰á gU¥ò 1 mî‹Þ 
 rhuiz nt® 1 mî‹Þ 
 R¡F   1 mî‹Þ 
 Kl¡f‰wh‹ nt® 1 mî‹Þ 
 ru¡Ffis bgho¤J 13 mî‹Þ ÚÇš ngh£L 6 mî‹Þ FoÚuhf 
FW¡» 1 ghyhil åj« âd« 2 ntis ju FHªijfË‹ m©l å¡f« 
FzkhF«. 
6.   Kl¡f‰wh‹ ïiy¢rhW  
 F¥ignkÅ rhW 
 K¡fh¢rhuiz r_y¢rhW  jyh 1 mî‹Þ 
 Mkz¡bf©bzŒ 
 ït‰iw mL¥ng‰¿ fhŒ¢á to¤J 1 ghyhil åj« bfhL¤J tu 
khªj tÈ¥ò ÔU«15. 
7. kfh Mdªj tÆutbd©bzŒ20 
8. Fk£o¡fhŒ gj§f«20 
9. nkfehj¤ ijy«31 
10. öJntis »Uj«17 
11. ïsÚh »Uj«17 
12. rŠÓÉ v©bzŒ15 
13. ÉlK£o ijy«15 
14. K¡T£L¤ ijy«39 
15. nkf fõha«39 
16. m©lthj x‰wl«56 
17. m©lthj v©bzŒ36 
18. bfhu£il¤ ijy«56 
19. ótur§fhba©bzŒ23 
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II.  REVIEW OF LITERATURE : BOTANICAL ASPECT 
MUDAKKATRAN - Cardiospermum halicacabum Linn.12 
Benthem & Hooker Classification : 
Kingdom - Plant Kingdom 
Division - Angiosperms 
Class  - Dicotyledonae 
Subclass - Polypetalae 
Series  - Discifloreae 
Order  - Sapindalis 
Family - Sapindaceae 
Genus  - Cardiospermum 
Species - halicacabum 
Vernacular Name2 
Sans - Jyotishmati 
Eng - Winter cherry, heart's pea 
Hind - Kanphata 
Ben - Nayaphataki 
Mal - Ulinja 
Tam - Mudakkatran 
Tel - Buddakakana 
Pun - habul-kalkal 
Arab - laftaf 
Part Used :  Whole plant, leaves and root. 
Geographical Distribution12 
 Through out India from the North west frontier to ceylon and Mallacca. 
It is distributed in most tropical and sub tropical countries. 
Description of the Plant :3, 12 
 Habit  - Annual or perennial 
 Leaves - Deltoid or ovate (1 1/2 - 3 inch) 
 Leaflets - Deeply cut; coarsely toothed. 
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 Flowers - White (3 - 4 mm) 
 Fruit  - Wide, broadly pyriform 
 Seeds  - Globose, smooth, black with a small white heart  
    shaped aril. 
 Inflorescence - Axillary, 2 tendriliferous at base, 3 - branched. 
Ethnomedical Importance : 2, 3 
1. On the Malabar coast, the leaves are administered in pulmonic 
complaints. 
2. The leaves mixed with castor oil are employed internally in 
rheumatism and lumbago. 
3. The whole plant rubbed up with water is applied to rheumatism and 
stiffness of the limbs. 
4. The whole plant, steepped in milk is successfully applied to reduce 
swellings and hardened tumours. 
5. In Punjab, the seed is used as a tonic in fever and a diaphoretic in 
rheumatism. 
6. The juice of plant promotes the catamenial flow during the menstrual 
period. 
7. It is dropped into ears to cure earache and discharge from the meatus. 
8. The root is given in scorpion - sting. 
9. An infusion of the leaf and stalk is given as an anema for dysenteries 
and diarrhoeas. 
10. Root and leaves of the herb in decoction are used in rheumatism , 
nervous disease, piles, chronic bronchitis, and phthisis. 
11. Leaves fried are applied to the pubes to increase the menstrual flow 
in amenorrhoea. 
12. Leaves boiled in oil such as castor oil are applied over rheumatic 
pains, swellings and tumours of various kinds. 
13. The whole plant has also been used both internally and externally in 
rheumatism and lumbago. 
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CHEMICAL CONSTITUENTS : 4,5 
 The whole plant contains, 
  Saponins 
  Traces of alkaloids 
  Flavonoids 
  Apigenin 
  Phytosteroids 
• Cardiospermum halicacabum ethanol as well as n-hexane extracts for 
their anti-pyretic activity against yeast induced pyrexia in rats. 
• Alkaloid fraction from seeds showed in vitro antibacterial action against 
some pathogenic organisms, caused transient hypotension and cardiac 
inhibition in anaesthetised dogs.  It blocked spasmogenic effects of 
acetyl choline, histamine and 5 - hydroxy tryptamine on guinea pig 
ileum and dog tracheal chain.  It had biphasic effect on frog rectus 
abdominis muscle. 
• Alcoholic extract of leaves produced cholinergic and antihistaminic 
effects on CVS and showed significant anti-inflammatory activity in 
rats.  It also produced CNS depression in near lethal doses and analgesic 
effect in mice and rats. 
• Alcoholic and aqueous extracts in vitro prevented cellular and extra 
cellular injuries by stabilising lysosomal membrane and prevented 
enzyme leakage. 
• Fatty acid content of seed oil 19.5 - 23.5%, (+) pin itol, 7-0- 
glucuronides of apigenin, chrysoeriol and luteolin isolated from leaves. 
• Seeds contain Amino acids, fatty acids, cyanolipids, methyl-4, 4-
dimetyoxy - 3 - buty rate, proteins. 
• Apigenin and its glycoside, arachidic acid, monomethylether of inositol, 
proanthocyanidin, saponin, β - sitosterol, its β -  D - galactoside and 
stigmasterol glycoside have been encountered in the plant. 
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MATERIALS AND METHODS  
 Mudakkatran Chooranam had selected for Vali Azahal Keellvayu 
(Rheumatoid Arthritis). 
Collection of the Test Drug : 
 The whole plant of Mudakkatran collected from Athimanjeri pet village, 
near Tiruttani, Tamil Nadu and they dried well under sun shade. 
Purification of the Raw Drug : 
 The whole plants were well rinsed in water and dried well. 
Preparation of the Test Drug : 
Chooranam : 
 The well dried mudakkatran plants were made into fine powder and 
sieved through white cloth (Vasthira kayam). 
Purification of Chooranam : 
• The fine powder of mudakkatran was then purified by steam cooking 
in milk (Chooranathooimai). 
• Then the powder was dried and sieved again. 
Drug Administration : 
 Route of Administration  : Enteral 
 Dose    : 1 gm. 
 Vehicle   : 60 ml. warm water. 
 Time of administration : Three times daily after food. 
Mudakkatran chooranam was subjected to the following tests. 
• Bio-chemical analysis. 
• Antimicrobial studies. 
• Pharmacological analysis 
• Clinical study 
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Figure 1 
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PHARMACOGNOSTIC STUDY 
 
Material and methods 
 The plant was collected from Anna Hospital campus, Arumbakkam, Chennai – 
600 106.  Free-hand as well as microtome sections of the root, stem, leaf and petiole 
were taken and double stained.  
Staining 
 Alcoholic safranin (0.5%) counter stained with 0.25% fast green.  This 
schedule gave good results for studying the histology of different tissues of the plant 
organs.  All slides, after staining in saffranin were dehydrated by employing graded 
series of ethyl alcohol (30%, 50%, 70%, 90% and absolute alcohol) and stained fast 
green in clove oil and xylol – alcohol (50-50) and passed through xylol and mounted 
in DPX mountant. Photomicrographs were taken with the help of Nikon microscope. 
Clearing of leaves for studying palisade ratio, stomatal number and stomatal index 
was done by using 5% sodium hydroxide along with chlorinated soda solution 
supplemented with gentle heat. 
Macroscopic: 
Root 
 Tap root, thick, reddish brown, hard, woody, branched rootlets, 2 to 50 mm 
thick. 
Stem 
 Stems and branches slender, wiry, twisted and ribbed. 
Leaf 
 Leaves alternate, exstipulate, long stalked, biternate, deltoid to broadly ovate.  
Leaflets, short stalked or sessile, oblong, thin and flaccid, nearly glabrous, palegreen 
above, deeply and coarsely serrate or dentate, narrowed at base and very acute or 
acuminate at apex.  Petiole longitudinally furrowed.  
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T.S. of Root 
 Transverse section of root shows outermost 3 or 4 layers of thin walled tabular 
cork cells, the outermost one or two layers flattened and crushed.  It is  followed by a 
phelloderm madeup of 4 – 8 layers of compactly arranged and tangentially elongated 
cells.  Group of phloem fibers are arranged as a discontinuous ring in the middle of 
cortical region.  Prismatic crystals are seen in some of the cells.   Phloem present.  
Xylem contains vessels of various diameters, medullary rays uniseriate, protoxylem 
points discernible among collapsed cells of pith (Fig.2A).   
 The secondary growth starts quite early and takes place in the normal way and 
soon the primary cortex and epidermis rupture away (Fig.2B).  
T.S. of Young stem 
 Transverse section of young stem shows  6 ridges and  6 grooves (Fig.2C).  It 
is differentiated into epidermis, cortex and stele.  Epidermis is madeup of thin walled 
single layered, parenchyma cells, protected by a thick cuticle (Fig. 2 E).  The cortical 
region shows a zone of 3 to 5 rows of collenchyma below the ribs and a zone of 3 to 5 
rows of chlorenchyma below the shallows.  Below this region is a one or two layers of 
thin walled parenchyma cells. Some of these cells contain prismatic calcium oxalate 
crystals (Fig.2D). Pericycle is represented by a zone of 7-9 rows of sclerenchyma 
fibres below the ribs and 3 or 4 rows of fibres below the shallows (Fig. 2 E). 
 The stele shows an irregular  ring of bicollateral vascular bundles, some of 
them being larger and some smaller. Primary phloem is composed of sieve tubes, 
companion cells, phloem fibres and phloem parenchyma.  Primary xylem is composed 
of xylem vessels, xylem fibres and xylem parenchyma.  Inner phloem is present 
below the primary xylem elements.  The pith is composed of large, thin walled 
parenchyma cells.  
T.S. of Mature stem 
 At regions where the activity of cork cambium is seen, the epidermis is 
ruptured and it is followed by a few rows of collenchyma cells or chlorenchyma cells 
which occur as patches alternating with each other.  Following this, a few uniform 
rows of tabular cork cells are found.    2 or 3 rows of parenchyma are found below 
this, which are supposed to represent the secondary cortex.  Secondary phloem forms 
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a continuous cylinder traversed by thick walled phloem rays.  The ring of cambium is 
represented by 2 or 3 rows of fusiform and ray initials.  Secondary xylem is 
represented by a large number of xylem vessels, tracheids and fibres. Vessels are 
mostly solitary and occasionally groups of 2 or 3 vessels are seen.  The secondary 
xylem is traversed by xylem rays.  The primary xylem is seen towards the centre with 
little primary inner phloem along with it.    
 The pith cells are parenchymatous.  Normal secondary growth is seen and the 
secondary vascular tissues are produced by the activity of the cambial ring formed by 
the union of fascicular and interfascicular cambium.  
T.S. of  Petiole 
 Transverse section of petiole is quadrangular in shape with 2 ribs and a groove 
along the adaxial side (Fig.2F).  The epidermis is single layered and covered by a thin 
cuticle.  Unicellular trichomes are seen.  Certain glandular hairs with a short stalk and 
multicellular head are also noticed.  The hypodermal region is composed of 
collenchyma below the ridges and chlorenchyma below the shallows (Fig.2F). It is 
followed by 4 or 5 rows of parenchyma cells.  The pericyclic sclerenchyma fibres 
completely encircles the 4 collateral vascular bundles present in the centre.  A small 
bundle is also present in between these 4 bundles.  4 to 6 rows of sclerenchyma are 
seen at the region of the bundles but only 2 or 3 rows of sclerenchyma are seen at 
other regions. 
 Pith is composed of thin walled parenchyma cells (Fig.) The 2 adaxial ribs are 
provided with a hypodermal zone madeup of 4 to 6 rows of collenchyma below the 
ribs and 3 rows of chlorenchyma at the shallow region.  The 2 leaf trace bundles are 
located in the 2 adaxial ribs, one bundle being present in each rib.  The leaf trace 
bundles are provided with the sclerenchymatous fibres along the outer side.   
The leaf 
T.S. of Midrib 
 Transverse section of midrib shows a conical projection on the adaxial surface 
and a larger semi globose projection on the abaxial side (Fig.3G,H).  The midrib is 
supplied by a single collateral vascular bundle, with xylem above and phloem below.  
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The rest of the midrib region is filled with parenchymatous cells.  Some of these cells 
contain cluster crystals. (Fig.3H). 
T.S. of Lamina 
 Dorsiventral in nature.  The mesophyll of the lamina is differentiated into 
palisade and spongy tissues.  The epidermis is single layered, madeup of large 
horizontally elongated cells.  The palisade layer is composed of a row of vertically 
elongated, closely arranged single layer of cells packed with chloroplastids (Fig.3I).  
The spongy tissue is composed of loosely arranged parenchyma with lesser number of 
chloroplastids.   Some cells of the mesophyll tissue contain druses of calcium oxalate 
crystals (Fig.3I).  Veins in the lamina portion are again supplied by a single vascular 
bundle.  
Epidermis in surface view  
 The adaxial foliar epidermis is madeup of larger cells with wavy outline 
(Fig.3J).  The abaxial foliar epidermial cells are same like that of adaxial epidermal 
cells but with very wavy contour (Fig.3K). Stomata are more numerous on the abaxial 
surface and of ranunculaceous or anomocytic type. Stomatal number 70-90-120 /mm2, 
and stomatal index 30-32-34/mm2 for upper epidermis: stomatal number 130-150-
170/ mm2, and stomatal index 36-39-42/mm2 for lower epidermis.   Palisade ratio 10-
12. 
Trichomes 
 Glandular trichomes are provided with a short stalk and globose multicellular 
head.  At times they are sunk in the epidermis.  Certain unicellular trichomes with 
bulbous base and pointed hairs are also present on the lamina.  They are partly sunk in 
the epidermis (Fig.3L,M). 
T.S. of Peduncle 
 Transverse section of peduncle shows 4 angles, 2 ribs being slightly largely 
than the other 2.  The hypodermal region of the rib is composed of collenchyma cells 
and shallow region is composed of 3 or 4 layers of chlorenchyma.  Below the 
hypodermis is the continuous ring of sclerenchymatous fibres.  About 5 rows of fibres 
are present below the ribs and about 2 or 3 rows of fibres are present at other regions. 
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Secondary growth in the vascular tissue is noticed.  Due to the cambial activity a 
continuous ring of phloem tissue is found below the sclerenchyma zone.  In the 
interfascicular regions 1 or 2 rows of xylem fibres are found and this along with the 
primary xylem forms more or less a continuous cylinder of xylem tissue.  Primary 
xylem is represented by xylem vessels and xylem fibres. Pith is madeup of slightly 
thick walled parenchymatous cells. 
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Figure - 2 
 
A T.S. of root 
B T.S. of root 
C T.S. of young stem 
D T.S. of stem showing prismatic  
 calcium oxalate crystal 
E T.S. of stem - A portion enlarged 
F T.S. of petiole 
Chl Chlorenchyma 
Ck Cork cells 
Co Collenchyma 
Cu Cuticle 
Ep Epidermis 
Mr Medullary ray 
Pc Prismatic calcium oxalate crystal 
Per Pericycle 
Ph Phloem 
Phe Phelloderm 
Pi Pith 
Sf Sclerenchyma fibre 
V Vessel 
Vb Vascular bundle 
Xy Xylem
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G T.S. of leaf 
H T.S. of Midrib 
I T.S. of lamina 
J Adaxial foliar epidermis 
K Abaxial foliar epidermis 
L, M Trichomes 
Co Collen cyhma 
Dr Druses of calcium oxalate crystal 
Ep Epidermis 
Gt Glandular trichome 
P Parenchyma cells 
Pa Palisade tissue 
Sp Spongy tissue 
St Stoma 
Tr Unicellular trichome 
Vb Vascular bundle 
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BIO-CHEMICAL ANALYSIS  
 
Preparation of  Extract 
 5 gm. of Mudakkatran Chooranam was weighed accurately and placed 
in a 250 ml clean beaker and added with 50 ml of distilled water. Then it was 
boiled well for about 10 minutes. Then it was cooled and filtered in a 100 ml 
volumetric flask and made upto 100 ml with distilled water. 
 
SI.No Experiment Observation  Inference 
1. I. Test for Acid Radicals 
1. Test for Sulphate : 
  
I. a) 2 ml of  the above prepared extract 
was taken in a test tube. To this add 2 
ml of 4% Ammonium oxalate 
solution. 
Cloudy 
appearance white 
precipitate was 
obtained  
Presence of 
sulphate 
b) 2 ml of Sodium carbonate extract 
was added with 2 ml of dilute 
Hydrochloric acid was until the 
effervescence ceases off. Then 2 ml 
of Barium chloride solution was 
added. 
White precipitate 
in soluble in Con. 
Hcl was obtained 
Sulphate was 
confirmed 
II. 5 drops of clear solution was added 
with 2 ml of dilute Sulphuric acid 
and slightly warmed. To this, 1 ml of 
dilute Potassium permanganate 
solution was added. 
KMnO4 solution 
was decolourised  
Presence of 
Oxalate. 
III. Test for Zinc: 
To the 2 ml of extract sodium 
hydroxide solution was added in 
drops to excess. 
White precipitate 
soluble in excess 
of sodium 
hydroxide. 
Zinc was 
confirmed. 
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IV. Test for Megnesium : 
To 2 ml of extract, Sodium 
hydroxide solution was added in 
drops to excess. 
White precipitate 
insoluble in 
excess of sodium 
hydroxide 
solution was 
obtained. 
Magnesium was 
confirmed. 
V. Test for Arsenic : 
2 ml of extract was treated with 2 ml 
of Silver nitrate solution. 
Brownish red 
pricipitate was 
obtained. 
Arsenic was 
confirmed. 
VI. Test for Tannic acid : 
2 ml of the extract was treated with 2 
ml of Ferric chloride solution. 
Black precipitate 
was obtained 
Presence of 
Tannic acid 
VII. Test for unsaturated compound : 
To 2 ml of  the extract 2 ml of 
Potassium permanganate solution 
was added. 
KMnO4  was 
decolourised 
Presence of 
unsaturated 
compound 
VIII. Test for Albumin : 
2 ml of the extract was added with 2 
ml of  Esboch's reagent. 
Yellow colour 
Precipitate 
formed. 
presence of 
Albumin. 
IX. Test for Type of compound : 
2 ml of the extract was added with 2 
ml of  Ferric chloride solution. 
Light green colour 
developed  
Oxyquinole 
epinephrine and 
pyrocatechol 
 
 The results of Bio-chemical analysis are shown in observation and 
results. 
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ANTI-MICROBIAL STUDY 
Preparation of Extract : 
 To 5 gms of Mudakkatran Chooranam 50 ml. of water was added and 
kept in a boiling water bath for 20 minutes and then filtered. 
 The extract of the drug was tested with the following micro organism. 
1. Staphylococcus aureus. 
2. Escherichia coli 
3. Klebsiella 
4. Proteus 
5. Pseudomonas 
6. Candida albicans. 
Procedure : 
 The tube dilution method was used as a homogenous dispersion of the 
drug was more effective to test the antimicrobial activity of the drug.  Dilution 
method was used in the preliminary screening of the antimicrobial activity. 
 To the 5 ml of Nutrient Broth culture 0.5 ml. of the extract was added 
and the tubes were incubated at 37oC overnight.  The next day the tubes were 
examined for turbidity and subcultures were made on Nutrient Agar plates.  
Control tubes without drug were also included.  The plates were incubated 
overnight at 37oC and the next day the reading was taken. 
 The results are shown in observation and results. 
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PHARMACOLOGICAL STUDIES 
 
ACUTE TOXICITY STUDY OF MUDAKKATRAN CHOORNAM 
MATERIALS AND METHODS 
Animals:  
 Randomly bred adult Wistar male and female rats from animal facility 
were used. They were housed in poly-propylene cages (6 per cage) with dust 
free rice husk as bedding material, and were provided with food and water ad 
libitum and rats for various acute toxicity studies. The rats for acute toxicity 
studies were fasted for 18 h before the experiment.  
Formulations:  
 Mudakkatran Choornam was prepared as a suspension with 2% CMC by 
mixing all the constituents and used  for acute toxicity studies.  
Haematological, biochemical and histological studies:  
 Three male and three female rats (200 to 250 g body weight) of nine 
group of animals were given upto the maximum of 4.0g.kg-1 of orally at 
different dose levels from the beginning of 50mg/kg using a 16 gauge oral 
feeding needle as per the OECD guidelines-420. An equal number served as 
control, given orally the vehicle only (8ml.kg-1 2% CMC). Twenty-four hours 
after the oral dosing the animals were lightly anaesthetised with ether and 
blood was withdrawn from the orbital plexus. They were then killed by cervical 
dislocation and vital organs were dissected out. Organ to body weight ratio, and 
various haematological and biochemical variables were studied. Tissues of vital 
organs viz., lung, liver, kidney, spleen, heart and testes or uterus were fixed in 
10% buffered formalin for microscopic examination. Standard procedures were 
used for the haematological, biochemical and histological parameters. 
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ANALGESIC ACTIVITY OF MUDAKKATRAN CHOORANAM IN 
LABORATORY ANIMALS 
MATERIALS AND METHODS 
Animals 
 Wistar Albino rats of either sex (180-200g) and mice (15 - 30 g) were 
housed in groups of 5 -6 animals in standard cages (23 x 38 x 23 cm) at 23-
30°C. They were provided with standard pellet diet and water ad libitum. The 
rats were kept for one week for acclimatization before the experimental 
sessions. The studies were approved by the CPCSEA and the local ethics 
committee. 
Drugs and Chemicals 
 Aspirin, Pentazocine, Acetic acid were used. The test drugs were 
suspended in distilled water using 1% CMC and administered in a volume of 1 
ml/100 g p.o.  
Preparation of stock solution 
 The test drug was mixed uniformly in 2% CMC and diluted with water 
to make the concentration as 10mg/ml. from this the appropriate dose was 
administered to the animals according to their body weight. 
Analgesic studies  
 The acute toxicity study showed the nontoxic effect upto 4g/kg body 
weight. Therefore one tenth and one fifth of the maximum dose used in the 
toxicity study were selected for the further study. The test drugs were 
administered at 400 or 800 mg/kg, p.o., 60 min before exposure to noxious 
stimuli. The standard drugs aspirin (100 mg/kg p.o.) were given 30 min before 
the test procedure. The studies involved three types of noxious stimuli.  
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Chemical:  
 Acetic acid-induced writhing in mice. The animals were divided into 
four groups consisting of six animals each. They were group I served as 
control-received 0.1ml of 2% acetic acid intraperitonially. Group II and III 
served as test received Mudakkatran Chooranam (400&800mg/kg. p.o.). Group 
IV served as standard-received Aspirin (100mg/kg.p.o.). After 30 min of drug 
treatment all the animals were treated with acetic acid to analyze the percentage 
of protection by the given test drugs.    
Thermal:  
 Two methods were employed for giving thermal stimuli, (i) Eddy’s hot 
plate method: the hot metal surface maintained at 55 ± 1°C, the sensitive 
animals (Mouse) were selected by subjecting them for basal reaction test. Then 
they were treated with drugs as described above. Pentazocine 5mg/kg ip, was 
used as a standard drug.. The paw licking or jumping response was considered 
as an end point. (ii) Tail flick method: Application of radiant heat to the mouse-
tail through a hot nichrome wire (5.5 ± 0.5 amps). The apparatus 
(Analgesiometer, Techno, India) used has a water jacket to maintain constant 
temperature around the stimulus area.  
Mechanical:  
 Mouse tail clip method. Mice pre-treated (60 min) with vehicle or test 
drugs (400&800 mg/kg po) were administered and Significant reduction in the 
reaction time of tail withdrawal after applying bulldog clip on tail was 
compared with vehicle treated animals was considered as antinociceptive 
response delay in tail withdrawal reflex was noted. 6 mice were used in each 
group. Experiments were conducted at room temperatures ranging between 30 
to 32°C. In both tail flick and tail clip methods the tail withdrawal response 
was considered as an end point. Comparisons was made with pretreatment or 
Normal control (0 h) values. 
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Anti-inflammatory activity of the Mudakkatran Chooranam in acute and 
chronic inflammatory models in rats 
Materials and Methods 
Animals:  
 Wistar Albino rats of either sex (180-200g) were housed in standard 
cages. They were provided with food and water ad libitum.  
Carrageenan induced rat paw oedema:  
 Acute inflammation was induced by subplantar injection of 0.1 ml. of 
1% freshly prepared suspension of carrageenan (Sigma Chemical Co.) into the 
right hind paw of each rat. The paw volume was measured at 0 and 2 h after the 
injection of carrageenan using a plethysmometer. The Mudakkatran Choornam 
(400 &800mg/kg) was administered orally. The standard drug aspirin 150 
mg/kg was administered orally. The control group received 0.9% saline 
10ml/kg orally. Drugs were given simultaneously along with the carrageenan 
injection. Mean increase in the volume of oedema was measured and the 
percentage of inhibition was calculated. 
Cotton pouch-induced granuloma:  
 Sub-acute inflammation was induced by cotton pellet granuloma. After 
shaving off the fur the animals were anesthetized; through a single needle 
incision, sterile preweighed cotton pellets (10 mg) one each were implanted in 
the axilla and groin region respectively of each rat. Mudakkatran Choornam 
(400 &800mg/kg), Aspirin (150 mg/kg) and 0.9% saline 10 ml/kg (control) 
were administered orally to the respective groups of animals for 7 consecutive 
days from the day of cotton-pellet implantation. On the eighth day the animals 
were sacrificed and the cotton pellets were removed and incubated at 60OC 
overnight and the dry weights were taken. The increment in the dry weight of 
the pellet was taken as a measure of granuloma formation.  
 The results are showed in Observation and Results. 
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CLINICAL ASSESSMENT 
 In Siddha system of medicine vali azahal keelvayu is classified under 
category of vadha disease and one among the type of 'keel vayu" 
 Sababathy Kaiedu describes the disease valie Azhal keelvayu as 
follows: 
 "thjã¤j¡ Ñš thíÉ‹ tU§F¿¢ rh‰w¡ nfshŒ 
 Vjkh® kªj nk¥g« ïiu¢rY« tÆ‰¿‰ fhQ« 
 XjU§F¤jš å¡f« XŒjÈš vÇ¢rY©lh« 
 fhjW Kw¡fÄ‹ik fhŒ¢rY§ fhQ§f©lhŒ"53 
nehŒF¿Fz§fŸ ; 
 czî brÇahkš KjÈš òËna¥gK©lhjš, mo¡fo fh‰W 
gÇjš, ky¡f£L, clš bgU¤jš KjÈa F¿Fz§fis fh£o 
kÂ¡f£L, fQ¡fhš, ÉušfŸ ïitfË‹ ÑšfŸ átªJ (Swelling of 
smaller Joints),  vÇ¢riyí«, ÄFªj tÈiaí« c©lh¡F«.  ïªnehŒ 
kU¤Jt¤â‰F ml§»D« Û©L« âU«g¤ âU«g tUtJkhÆU¡F«.  
nk‰f©l ÑšfŸ fuL f£o Ú£lî« e‹whŒ kl¡fî« Koahkš 
(Morning Stiffness & Restriction of Movements) Ãiy¤J Ã‰fî« brŒí«. 
ö¡fÄ‹ik, gL¡ifÆš òusš, áWRu« KjÈad V‰gL«. 
ehoeil : 
 "âU¤jkh« thj¤njhnl Ô§bfhL ã¤jŠ nrÇ‰ 
 bghU¤JfŸ njhW« behªJ nghjnt ão¡F«" 
      (nehÆ‹ rhu«) 
 "ïlkhd nr¤Jk¤âš ã¤j eho 
 vGªjQ»š ÉlKlnd å¡fK©lh«" 
      (rjf eho) 
 "fhz¥gh thj Û¿š fhšiffŸ bghUªâ nehF«" 
      (fhÉa eho) 
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 "thj¤âš nr¤Jk kh»š tÈnahL å¡fK©lh«" 
      (mf¤âa® eho) 
ABOUT THE DISEASE: 
• The disease Vali Azhal Keelvayu is closely related with the disease 
Rheumatoid Arthritis, mentioned in modern medicine. 
• Rhematoid Arthritis is the most common form of arthritis. 
• Rheumatoid Arthritis was the term introduced by Sir. Alfred Barring 
Garrod in 1859 to describe a chronic inflammatory disease of 
peripheral joints. 
Definition: 
 Rheumatoid Arthritis is a symmetrical destructive and deforming 
polyarthritis affecting small and large synovial joins associated with systemic 
disturbance, a variety of extra articular features and the presence of circulating 
anti globuling antibodies (Rhematoid factors)  
Aetiology : 
 Although the cause of Rheumatoid Arthritis remains obscure, there is 
increasing evidence that the disease is triggered by T. lymphocyte in genitically 
predisposed individuals with define HLA class II haplotypes.  HLA - DR4 is 
the major susceptibility haplo type in most ethnic group, but DR1 is more 
important in Indians.  HLA-DR4 sub types result from only few amino acid 
difference in the third hyper variable region of the amino acid sequence 
through several other HLA allies that have more recently been associated with 
RA in some populations. 
Pathology : 
 The pathogenic hall mark of RA is synovial membrane proliferation and 
out growth associated with erosion of articular cartilage and subchondral bone.  
Often linked to proliferating inflammatory tissue (pannus) may lead 
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subsequently to destruction of intellectual and periarticular structures and may 
result in joint deformities and dysfunction seen clinically. 
CLINICAL FEATURES : 
I.  Articular Manifestation : 
 Most commonly involved joints are small joints of the hands, wrists, 
knees and feet with time the disease also may affect the elbows, shoulders, 
sternoclavicular joints, hips and ankles.  The temperomandibular and 
cricoarytenoid joints are less frequently involved.  Spinal involvement is 
generally limited to the upper cervical articulations. 
Hand : 
 Swelling of PIP joints giving a fusiform or spindle shaped appearance to 
the fingers.  Bilateral and symmetrical swelling of the MCP joints is also 
frequent. 
 Swan neck deformities develp from hyper extension of the PIP joints in 
conjunction with flexion of DIP joint. 
 Boutonniere (Button Hole) deformities results from flexion contract of 
the PIP joints associated with hyper extension of the DIP joints. 
Wrists :  
 The wrists are almost invariable involved and demonstrate palpable 
boggy synovium and thenar muscle wasting may be evident. 
Knees : 
 Synovial proliferation and effusion are common.  Ballotment on the 
patella or buldge sign may due to effusion popliteal cysts (Barker's) may form 
owing to effusion or synovial proliferation in to semimembraneous bursa. 
Feet and Ankles : 
 Subluxation of the metatarsal heads into soles often with valgus 
deformities of the toes. 
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Neck : 
 Neck pain and stiffness are common.  Atlanto axial subluxation (C1 on 
C2) can be seen in upto radiographically in 30% of cases.  Spinal compression 
may lead to bladder or bowel incontinence or quadriplegia. 
Elbows : 
 Proliferation synovitis in the elbow. 
Hip : 
 Pain in the groin, lateral buttock, lower back may indicate hip 
involvement. 
II.  EXTRA ARTICULAR MANIFESTATIONS : 
Skin : 
 Subcutaneous nodules, palmar erythema and fragility of the Skin, 
Rheumatoid vasculitis. 
Cardiac Manifestations : 
 Pericarditis, Conduction system block, coronary vasculities, 
myocarditis, endocarditis, pericardial fluid shows low glucose level, elevated 
lactate dehydrenase. 
Pulmonary Manifestation : 
 Pleurisy, pleural effusion, nodules in lung parenchyma chronic 
interstitial fibrosis, irreversible respiratory insufficiency. 
Neurologic Manifestation : 
 Peripheral neuropathy produced by proliferating synovium causing 
compression of nerves, carpal tunnel syndrome, tarsal tunnel syndrome often 
associated with wrist and foot drop. 
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Opthalmic Manifestation : 
 Sjogren's syndrome cause corneal damage associated with dryness of 
eyes.  Scleritis may result in visual impairment. 
Felty's Syndrome : 
 Triad of chronic Rheumatoid Arthritis, Spleenomegaly and neutropenia 
is associated with lymphadenopathy. 
DIAGNOSTIC CRETERIA FOR RA : 
(By the American Rheumatism Association) 
1. Morning stiffness of more than 1/2 hour duration. 
2. Pain or tenderness in atleast one joint. 
3. Joint swelling of atleast one joint observed by physician. 
4. Swelling of atleast one other joint has observed by physician, with a 
three month interval between the appearance of the 2 joint swelling. 
5. Symmetrical swelling of indentical joints except distal interphalangeal 
joint. 
6. Subcutaneous nodules. 
7. X Ray changes of RA. 
Selection of Patients : 
 To study the efficacy of the drug "Mudakkatran Chooranam" in Vali 
Azhal Keel Vayu 40 patients were selected between the age group of 30 - 70 
years, were treated as out patients in Govt. Arignar Anna Hospital, Chennai.  
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INCLUDING CRETERIA EXCLUDING CRETERIA 
• Pain 
• Morning stiffness 
• Joint swelling 
• Tenderness 
• Restricted joint motion 
• Fever 
• Osteo arthritis 
• Gout 
• Tubercular arthritis 
• Psoriatic arthritis 
• Gonococcal arthritis 
• Juvenile RA 
• Rheumatic fever 
• Subcutaneous nodules. 
• RA with swan neck deformity, 
button hole deformity, Ulnar 
deviation.
 
Radiological Finding : 
• Soft tissue swelling 
• Narrrowing of joint space due to cartilage destruction  
Line of treatment : 
 All the selected patients were undergone the blood and urine 
examination.  They were diagnosed as "Vali Azhal Keel Vayu" by the history 
of symptoms., physical examination and confirmed by radiological findings.  
Then they were treated with Mudakkatran Chooranam with the dosage of 1 gm. 
With warm water 3 times a day after meals and the treatment was continued 
upto the improvement of symptoms. 
Diet restriction and Medical Advise : 
• The patients were advised to avoid food like root tubers, dhal and others 
which increase vadha kutram. 
• Obese patients were advised to reduce their weight to avoid further 
stress on joints. 
• Advise to perform mild exercises both strengthening and aerobic (In 
order to strengthen the quadriceps muscles)13.  
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BIO-STATISTICAL STUDY 
 
 Bio-statistical study was carried out 40 out-patients in Post-graduate's 
Department of Gunapadam, Govt. Siddha Medical College attached to Arignar 
Anna Hospital of Indian Medicine, Chennai - 106. 
CRETERIA FOR SELECTION OF BIO-STATISTICS 
 Analysis of Subjective parameters : (Before and After Treatment)  
• Pain 
• Swelling 
• Morning Stiffness 
 The results of Bio-statistical analysis of subjective parameters are 
explained at Results and Observation (Table - 3). 
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OBSERVATION AND RESULTS 
 Mudakkatran chooranam the trial drug was undergone Bio-chemical 
analysis, Antimicrobial study, Pharmacological study, clinical study and Bio-
statistical study and the results were observed. 
Physico - Chemical standards of Mudakkatran Chooranam : 
Loss on drying @ 105oC 6.96% 
Ash Value 7.01% 
Water Solublity 12.58% 
Acid insoluble ash 0.84% 
Alkalinity as CaCO3 in water soluble ash 0.24% 
pH at 10% aqueous solution 5.35 
 
Inorganic analysis -  Quantitative : 
Zinc as Zn 40 mg/Kg. 
Iron as Fe 706 mg/Kg. 
Magnesium as Mg 0.28 % 
 
BIO-CHEMICAL ANALYSIS : 
 Done at Govt. Siddha Medical College, Chennai - 106.  The extract of 
Mudakkatran Chooranam showed the presence of  
Acid Radicals : 
 Sulphate,  Oxalate 
Basic Radicals : 
 Zinc,  Magnesium,  Iron, Arsenic 
Miscellaneous : 
 Tannic acid,  Albumin,  Unsaturated compound 
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ANTI MICROBIAL STUDY : 
 In vitro antimicrobial activity of Mudakkatran Chooranam extract 
showed that the drug was sensitive to staphylococcus aureus and resistant to E-
coli, klebsiella, proteus, pseudomonas and candida albicans. 
PHARMACOLOGICAL STUDY : 
Acute toxicity studies of Mudakkatran Choornam 
Results 
Haematological, biochemical and histological studies:  
 Rats administered with 4.0g/kg orally did not show any toxic signs and 
symptoms. The studies carried out on various clinical parameters and histology 
did not reveal any toxicity induced changes. 24 hr after oral administration the 
male rats showed an increase in WBC counts, increase in urea level and 
changes in the relative weight of lung and liver. There was no significant 
change in rats administered 50mg/kg to 4.0 g/kg Mudakkatran Choornam did 
not show any significant change compared to the control during the 4 h post 
administration period.  
Discussion 
 A dose of 4.0 g/kg of Mudakkatran Choornam given orally did not alter 
the haematological, biochemical and histological parameters. A few significant 
changes observed were also within normal clinical limits. Oral administration 
of Mudakkatran Choornam did not show any hepatotoxicity or nephrotoxicity 
in the histological examination, though the urea levels were slightly increased 
in male rats. Mudakkatran Choornam is a nonirritant and has a better safety. 
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Good stability and extremely low toxicity of formulation of Mudakkatran 
Choornam makes it a favourable. 
Analgesic activity of Mudakkatran Chooranam 
Results 
Analgesic activity 
 Test drug Mudakkatran Chooranam at two dose levels (400&800 mg/kg, 
p.o.)  were studied and they exhibited significant dose dependent 
antinociceptive effect as measured by tail flicks, Tail clip method, hot plate 
method, in rats and chemically induced abdominal constrictions in mice. 
Chemical stimulus: Acetic acid induced writhing 
 The test drug MC (400&800 mg/kg, p.o.) significantly reduced (p < 
0.001) the number of writhing episodes in treated mice. Mudakkatran 
Chooranam elicited more analgesic activity vs aspirin – treated animals (p< 
0.01). The analgesic effect shown by MC were not significantly different from 
that of aspirin group indicating comparable activity at the doses used. 
Thermal stimuli: Eddy’s hot plate and analgesiometer 
 Both the standard (Pentazocine: 5mg/kg ip, - 30 min) and the test drugs 
(Mudakkatran Chooranam 400&800 mg/kg po, -60 min) showed marked 
analgesic effects when tested on Eddys’ hot plate (mice) and Analgesiometer 
(rats) as evidenced by significant increase (p< 0.01) in reaction time to thermal 
noxious stimuli. The reaction times were significantly lower (p <0.05 to < 0.01) 
in test drug and standard drug treated groups than in control group. But the test 
drug treated group indicating less analgesic potency than the standard drug.  
Mechanical stimuli:  
 Mudakkatran Chooranam at both the dose levels (400&800 mg/kg, p.o.)  
Were exhibited significant dose dependent antinociceptive effect as measured 
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by Tail clip method, Significant increase in the reaction time of tail withdrawal 
reflux after applying bulldog clip on tail was observed in drug treated animals. 
Discussion 
 All the mice attempted to dislodge the clip within 2-3 seconds. The all-
or-none criteria in the tail clip test was used. The test drugs exhibited moderate 
to marked analgesic effects. Traditionally Mudakkatran Chooranam are 
claimed to be useful in painful inflammatory conditions and Rheumatoid 
Arthritis. The results show that the test drugs exhibited analgesic activity 
against chemical, thermal and mechanical stimuli at the doses used. In the 
present study, the analgesic activity was observed at 400-800 mg/kg p.o., the 
maximum tolerated dose of test drugs was found to be >4g/kg p.o. indicating 
wide margin of safety.  
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Table- 1.  Analgesic effects of Mudakkatran Chooranam in laboratory animals 
Groups Dose Used 
Mg/Kg body 
weight 
Writhing test 
(No. of 
writhings in 
10min) 
Tail-flick test 
Reaction time (sec) 
Tail-clip test 
Reaction time (sec) 
Eddy’s hot plate method 
Reaction time (Sec) 
Basal After drug Basal After drug Basal After drug 
Control  1ml CMC  44.83±1.30 1.87±0.06 1.82±0.01 2.45±0.76 2.44±0.07 1.83±0.04 1.8±0.02 
Test1 400 26.66±0.88** 1.81±0.04 2.39±0.04** 2.3±0.19 2.8±0.06* 1.90±0.06 1.95±0.06ns 
Test2 800 25.5±1.17** 2.03±0.04 3.88±0.03** 2.28±0.08 2.8±0.1* 1.97±0.06 3.58±0.17** 
Standard  Asp-100, Pen-5, 22.83±0.94** 1.88±0.22 4.9±0.02** 2.13±0.1 4.83±0.07** 1.96±0.04 5.85±0.09** 
Values are mean ± SEM (n = 6); *P<0.05; **P<0.01 considered as significantly different from control or Pretreatment values 
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Antiinflammatory activity of The Mudakkatran Choornam 
Results 
 Mudakkatran Choornam in a dose of 400&800mg/kg exhibited 
significant antiinflammatory activity in both acute and sub-acute models (Table 
2). Mudakkatran Choornam 400mg/kg exhibited maximum inhibition of 
41.00% and Mudakkatran Choornam 800mg/kg showed an inhibition of 
33.08%, while the standard drugs aspirin showed an inhibition of 51.25% 
respectively (P<0.001) in the carrageenan induced rat paw oedema (acute) 
model. 
In the sub-acute model of inflammation (cotton pouch granuloma), 
Mudakkatran Choornam exhibited significant (P<0.001) reduction in the 
granuloma weight 43.53% and 42.10% respectively. These results were 
comparable with that of the standard drugs, Aspirin 43.28%.  
Discussion 
 The results of the present investigation suggest that Mudakkatran 
Choornam produced significant antiinflammatory effect. Carrageenan induced 
inflammatory process is believed to be biphasic. The initial phase seen at the 
1st hour is attributed to the release of histamine and serotonin. The second 
accelerating phase of swelling is due to the release of prostaglandin, bradykinin 
and lysozyme. It has been reported that the second phase of edema is sensitive 
to clinically useful non-steroidal anti-inflammatory agent. The anti 
inflammatory activity exerted by Mudakkatran Choornam suggest that they 
could have acted by affecting kinnin, prostaglandin, bradykinin and lysozyme 
synthesis. In the cotton pouch granuloma test significant antiinflammatory 
activity (P<0.001) were exerted by the Mudakkatran Choornam. Its efficacy to 
inhibit the inflammation might be due to an increase in the number of 
fibroblasts and synthesis of collagen and mucopolysaccharides during 
granuloma tissue formation. 
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Table 2: Effect of Mudakkatran Choornam on carrageenan induced paw oedema and 
cotton-pouch granuloma in rats. 
Drug Dose 
mg/kg, 
p.o 
Carrageenan induced rat 
paw oedema 
Cotton-pouch granuloma  
Vol. of rat paw 
oedema (ml) 
mean±SEM 
*** 
Percent 
Inhibitio
n 
Weight of 
granuloma 
(mg) 
mean±SEM**
* 
Percent 
Inhibitio
n 
Control(2% 
CMC) 
10 
ml/kg 
1.26±0.071 ----------
- 
71.89±2.91 ------- 
Aspirin 150 0.645±0.006 51.25 40.77±1.713 43.28 
MC-1 400 0.708±0.007 41 40.59±2.313 43.53 
MC-2 800 0.803±0.008 33.08 41.62±1.963 42.10 
 
Values are mean±SEM. n=6 in each group. ***P< 0.001 when compared to control. 
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OBSERVATION AND RESULTS OF CLINICAL STUDY 
 The trial drug was given daily to the patients and they were examined 
clinically with keen observation. 
 Reduction of pain, morning stiffness and swelling is an important sign 
or progress.  The duration of the treatment ranged between 50 - 70 days 
according to the severity of the signs and symptoms of the patients. 
The observation regarding, 
• Age variation 
• Sex difference 
• Signs and symptoms during admission. 
• Results 
• Improvement showing sign and symptoms after treatment are recorded 
and tabulated as follows : 
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Results : 
 The results are based on the clinical improvement on signs and 
symptoms before and after treatment. 
• The total relief from symptoms was considered as good relief. 
• The relief from pain, swelling, tenderness and morning stiffness were 
considered as moderate relief. 
• The relief from less than four symptoms were considered as mild relief.
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CLINICAL STUDY ON MUDAKKATRAN CHOORANAM IN OUT PATIENT DEPARTMENT IN THE  
MANAGEMENT OF VALI AZHAL KEELVAYU 
S.  
No 
O.P. 
No. 
Name, 
Age / Sex 
Complaints 
Duration of 
Treatment 
in days 
BT & 
AT 
BLOOD URINE 
X - Ray Results TC Cells 
/ Cumm 
DC (%) ESR (mm) Hb  
g % 
Sug 
mg% 
Ur 
mg% 
Cho 
mg% 
RA 
Factor CRP 
ASO  
titre Alb Sug Dep P % L % E % 1/2 Hr. 1 Hr. 
1 7939 
Kamala 
45/F 
Pain, swelling, tenderness, restriction of both 
wrist joints movement 56 
BT 10900 68 30 2 27 45 13 132 32 217    N N N  
Good 
AT 9800 67 30 3 15 29 12.5 124 30 220    N N N  
2 8164 
Chandiran 
47/M 
Pain, swelling, tenderness in Lt. MCP, 
both MTP 70 
BT 9100 53 41 6 44 80 10 113 30 214 (-) (+) (-) N N OPC  
Good 
AT 8700 67 30 3 22 32 10 127 24 220 (-) (-) (-) N N N  
3 9129 
Gnanasekar 
53/M 
pain, tenderness in Rt. Elbow, swelling, 
morning stiffness in both MCP. 63 
BT 9600 52 40 8 25 42 10.5 143 27 207    N N N  
Good 
AT 9100 56 40 4 7 20 10 135 21 198    N N N  
4 1530 
Lakshmi 
40/F 
Swelling, morning stiffness, tenderness, in 
Lt. MCP, fever. 56 
BT 8600 59 37 4 20 38 11 101 18 163 (-) (+) (-) N N FEC   
Moderate AT 9800 60 35 5 12 20 11 84 23 180    N N FEC  
5 1666 
Lalitha 
40/F 
Swelling, tenderness in right shoulder, 
both MCP, fever 70 
BT 9800 60 36 4 24 40 10.5 108 27 193    N N OPC  
Mild 
AT 9600 58 35 7 25 48 10.5 138 23 162    N N EPC  
6 1685 
Pichaiammal 
42/F 
Swelling, tenderness, morning stiffness, in 
both MCP, Rt. MTP 56 
BT 9300 55 41 4 112 200 9 140 21 182    N N N  
Good 
AT 10100 70 25 4 80 110 8 127 20 191    N N N  
7 1841 
Rajalakshmi 
55/F 
Swelling, tenderness, morning stiffness in 
Lt. MCP, both knee, Rt. ankle, both MTP, 
loss of apptite 
63 
BT 7900 56 36 8 30 54 12 136 27 185    N N OPC Os.Ch. 
Good 
AT 8500 60 36 4 20 42 12 140 25 169    N N N Os.Ch. 
8 2027 
Anandh 
40/M 
Swelling, tenderness in Lt. shoulder both 
MCP, Lt. Knee, both ankle. 56 
BT 10100 63 33 4 18 33 11.5 110 17 194    N N N   
Good AT 10000 70 27 3 8 20 12 93 21 180    N N N  
9 2096 
Jeyachitra 
30/F 
Swelling, tenderness, morning stiffness in 
Rt. PIP, Rt. MCP Lt. wrist, Lt. Knee. 63 
BT 9300 64 34 2 9 22 10 115 32 210    N N OPC NOJS  
Good AT 9800 65 30 5 5 13 11 110 30 220    N N N NOJS 
10 3596 
Selvaraj 
37/M 
Swelling, tenderness, morning stiffness in 
Lt. Elbow, both knees, Rt. MTP 63 
BT 9800 57 39 4 14 30 11 150 18 179 (-) (-) (-) N N FPC   
Good AT 10200 61 37 2 10 18 11 146 24 182    N N N  
11 4480 
Meenakshi 
42/F 
Tenderness, morning stiffness in both PIP, 
Lt. MCP, Rt. shoulder joint, loss of 
appetite 
70 
BT 8700 54 41 5 52 90 9.8 98 23 177    N N N   
Good AT 9200 63 30 7 30 62 9.5 85 21 182    N N OPC  
12 6125 
Muthu 
50/M 
Tenderness, morning stiffness in both 
MCP, PIP, Knee joint, loss of appetite 56 
BT 9800 57 38 5 5 9 11 86 18 175    N N FPC Os. Ch. 
Good 
AT 10500 60 36 4 4 8 10 94 21 180    N N FEC Nil 
13 6255 
Tamilarasi 
38/F 
Pain, tenderness, morning stiffness in both 
MCP, both wrist, Rt. knee 63 
BT 9200 54 42 4 20 42 9 138 26 167 (+) (+) (-) N N FPC  
Good 
AT 9000 60 34 6 10 22 9.5 126 25 184 (-) (-) (-) N N N  
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S.  
No 
O.P. 
No. 
Name, 
Age / Sex 
Complaints 
Duration of 
Treatment 
in days 
BT & 
AT 
BLOOD URINE 
X - Ray Results TC Cells 
/ Cumm 
DC (%) ESR (mm) Hb  
g % 
Sug 
mg% 
Ur 
mg% 
Cho 
mg% 
RA 
Factor CRP 
ASO  
titre Alb Sug Dep P % L % E % 1/2 Hr. 1 Hr. 
14 6947 Rasubee 
47/F 
Swelling, morning stiffness, tenderness in 
both PIP and MCP fever 63 
BT 9100 53 39 8 12 20 7.5 82 25 156    N N OPC  
Moderate 
AT 9500 57 35 8 8 15 8 92 28 169    N N OPC  
15 7293 Yadodha 
36/F 
Pain, swelling, tenderness in Lt. shoulder, 
elbow joints 63 
BT 10700 62 33 5 12 25 10.5 83 19 172    N N N  
Good 
AT 10100 65 33 2 4 9 11 100 23 178    N N N  
16 9191 Gragalakshmi 
52/F 
Tenderness, morning stiffness, in both 
MCP & PIP 63 
BT 7200 65 33 2 5 12 12.2 112 20 170 (-) (-) (-) N N N  
Good 
AT 8300 60 37 3 5 9 12 96 18 169    N N N  
17 160 
Sulakshana 
35/F 
Swelling, tenderness morning stiffness in 
Rt. hip and knee joint, fever, loss of 
appetite 
56 
BT 8600 67 30 3 38 65 14 104 22 215    N N FEC  
Moderate 
AT 9100 58 40 2 22 40 13 115 20 207    N N FEC  
18 1445 
Nagammal  
48/F 
Pain, swelling, morning stiffness in both 
PIP and MCP, fever 63 
BT 6400 52 46 2 12 28 12.2 130 20 144 (+) (+)  N N N  
Good 
AT 7200 57 40 3 10 18 13 130 18 154    N N N  
19 1743 
Jeyalakshmi 
50/F 
Pain in both knee, swelling, tenderness in 
both PIP & MCP, fever 63 
BT 7700 60 35 3 44 77 13 115 24 187 (-) (-) (-) N N N  
Mild 
AT 8500 53 39 8 15 25 13 117 31 187    N N N  
20 2182 Elumalai 
32/M 
pain, swelling, tenderness, morning 
stiffness in both MCP, PIP, Rt. and Lt. 
ankle joints 
56 
BT 10700 62 33 5 11 20 11 78 26 174 (-) (-) (-) N N FPC  
Good 
AT 10200 64 31 5 8 12 10.5 83 25 182    N N FPC  
21 3840 Kalaimani 
24/F 
Swelling, pain, tenderness, morning 
stiffness in both knee, Lt. PCP, MCP 56 
BT 9000 57 36 7 5 9 9 135 23 169    N N FEC  
Good 
AT 9600 55 36 9 15 22 9 130 24 187    N N N  
22 5584 
Kulanjiammal 
30/F 
Pain, swelling, morning stiffness, 
tenderness in Rt. knee joint, Rt. MCP, loss 
of appetite 
56 
BT 9400 57 38 5 5 12 9 138 18 169    N N OEC  
Good 
AT 9700 59 34 7 5 10 9.5 115 19 170    N N N  
23 5891 Selvam 
45/M 
Pain, swelling, tenderness, morning 
stiffness in Lt. MCP, PIP, Both shoulder 
joint 
63 
BT 9400 64 31 5 18 40 9.6 120 23 195    N N N  
Moderate 
AT 9700 65 32 3 10 18 9 97 20 204    N N N  
24 5906 
Shanthi 
50/F 
Pain, swelling, tenderness, morning 
stiffness in both knee Rt. ankle joint. 56 
BT 8500 68 30 2 30 60 9 113 27 156 (+) (+) (+) Tr. N N  
Good 
AT 8900 65 32 3 20 32 10 110 22 169 (-) (-) (-) N N N  
25 6069 
Narayanan 
63/M 
Pain, swelling, tenderness morning 
stiffness in Rt. & Lt. PIP 63 
BT 7700 56 40 4 20 43 10 100 26 185 (+) (-) (-) N N N  
Good 
AT 8600 65 25 10 15 32 11 117 24 203    N N N  
26 6190 
Jeeva 
48/M 
Pain, swelling, tenderness, morning 
stiffness in Rt. knee joint, both MCP 63 
BT 9800 62 32 6 15 19 11 113 19 213    N N N  
Moderate 
AT 9200 60 37 3 6 12 11 110 23 220    N N N  
S.  
No 
O.P. 
No. 
Name, 
Age / Sex 
Complaints 
Duration of 
Treatment 
in days 
BT & 
AT 
BLOOD URINE 
X - Ray Results TC Cells 
/ Cumm 
DC (%) ESR (mm) Hb  
g % 
Sug 
mg% 
Ur 
mg% 
Cho 
mg% 
RA 
Factor CRP 
ASO  
titre Alb Sug Dep P % L % E % 1/2 Hr. 1 Hr. 
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27 7438 
Girija 
40/F 
Pain, tenderness, morning stiffness in both 
MCP, knee joint. 63 
BT 10800 67 30 3 58 105 13 107 25 200    N N FEC  
Good 
AT 9700 61 33 6 35 48 12 110 24 192    N N   
28 7635 
Rani 
40/F 
Pain, swelling, tenderness, morning 
stiffness in Rt. PIP 63 
BT 9200 62 33 5 10 22 8.5 98 19 172 (-) (-) (+) N N FEC  
Good 
AT 9800 57 40 3 10 15 9 110 18 192    N N FPC  
29 8028 
Tamilthara 
38/F 
Pain, swelling, tenderness, morning 
stiffness in both ankle, PIP, MCP 56 
BT 10500 54 40 6 22 38 11 138 27 230 (+) (+)  N N N  
Good 
AT 8700 67 30 3 12 32 11 127 25 170 (-) (+) (-) N N FPC  
30 9186 
Vasanthi 
35/F 
Pain, swelling, tenderness, morning 
stiffness in both knee and wrist joints. 63 
BT 9000 59 34 7 30 60 10 93 21 170    N N N  
Good 
AT 9800 59 34 6 15 32 10 84 23 188    N N N  
31 9878 
Chitra 
32/F 
Pain, swelling, morning stiffness in both 
knee, MCP joints 63 
BT 9700 72 26 2 16 42 14.4 105 28 182 (-) (-) (+) N N N  
Good 
AT 10500 58 38 4 7 16 14 98 24 165    N N N  
32 1831 
C. Selvi 
39/F 
Pain, swelling, morning stiffness, 
tenderness in Rt. knee joint 56 
BT 11100 55 41 4 38 78 12 123 30 207    N N N  
Moderate 
AT 10900 62 36 2 15 38 12 120 31 210    N N N  
33 5489 Chitra 
35/F 
Pain, swelling, morning stiffness 
tenderness in all PIP, MCP, both knee, 
elbow, hip and shoulder joints 
56 
BT 9200 58 30 12 50 104 7 93 27 167 (+)   N N FPC Os.Ch. 
Good 
AT 10000 60 32 8 25 44 9 98 24 186 (-) (-) (-) N N N N 
34 6234 Murugan 
24 / M 
Pain, tenderness,morning stiffness in Rt. 
MCP, PIP and shoulder joints, fever 63 
BT 8800 65 30 5 8 15 11 140 35 196 (-) (+) (-) N N N  
Good 
AT 9300 63 33 4 15 26 12 132 30 194 (-) (-) (-) N N N  
35 8852 Salamen 
65/M 
Pain, swelling, tenderness, in Rt. PIP, 
MCP and Lt. hip joint 63 
BT 9400 58 36 6 60 124 9 89 24 210    N N N  
Moderate 
AT 10100 59 38 3 35 68 9 96 18 207    N N N  
36 8880 Veeramani 
52/M 
Pain, swelling morning stiffness in Rt. PIP, 
MCP 56 
BT 10500 60 38 2 15 24 14 81 32 214 (+) (+) (-) N N N  
Good 
AT 10200 57 42 1 7 12 14 87 30 200 (-) (-) (-) N N N  
37 934 Jeyasri 
36/F 
Pain, swelling, tenderness in both MCP 56 
BT 8400 50 46 4 15 36 13 125 22 159 (-) (-) (-) N N N  
Good 
AT 9100 63 36 1 8 17 12 120 27 163    N N N  
38 1346 Vasumathi 
24/F 
Pain, swelling, morning stiffness in both 
MCP, loss of appetite 63 
BT 9400 52 44 4 10 18 11 99 18 153 (-)   N N FEC  
Good 
AT 9400 58 36 6 5 12 10.5 83 18 165    N N OPC  
39 2708 Bhavani 
37/F 
Pain, swelling, morning stiffness in both 
knee joints, Rt. MTP 56 
BT 9800 60 32 8 25 52 10.5 268 23 172    N N OPC Os.Ch. 
Good 
AT 10200 60 30 10 13 26 10.5 252 24 196    N N OPC N 
40 3816 Rajamani 
60/F 
Pain, swelling, morning stiffness 
tenderness in MCP, PIP of both hands 56 
BT 7500 55 38 7 24 40 11 140 14 166    N N N  
Good 
AT 7900 55 39 6 30 48 11 133 18 173    N N N  
 
 
Abbreviation : 
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BT - Before Treatment, AT - After Treatment, TC - Total WBC Count, DC - Differential Count, Hb - Haemoglobin, 
Sug - Glucose, Ur - Urea, Cho- Cholesterol, Alb - Albumin, Dep. - Deposit, OPC - Occasional Pus Cells,  
FPC - Few Pus Cells, N - Nil, P - Neutrophills, L - Lyphocytes, E - Eosinophills, (+) - Postive,  (-) - Negative,  
Os. Ch. - Osteophytic Changes, NOJS - Narrowing of Joint Space,  Tr. - Trace 
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BEFORE TREATMENT 
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AFTER TREATMENT 
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Table - 3 :  Results of Statistical analysis of subjective parameters observed 
before and after treatment of (n = 40) patients. 
S. 
No. 
Parameters Percentage present Statistical 
test 
criterion 
Probability 
Value (P) 
Statistical 
Significance 
of the 
Difference 
Before 
Treatment 
After 
Treatment 
Difference 
1 Pain 40/40 
(100) 
32/40 (80) 20.00 Z = 9.8 < 0.05 Significant 
2 Swelling 34/40 (85) 24/34 
(70.58) 
29.41 Z = 7.7 < 0.05 Significant 
3. Morning 
Stiffness 
32/40 (80) 26/32 
(81.25) 
18.75 Z = 7.2 < 0.05 Significant 
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DISCUSSION 
 The whole plant of Mudakkatran (Cardiospermum halicacabum) was 
selected to find its efficacy in the treatment of the disease "Vali Azhal 
Keelvayu". 
 Literature evidences were collected from various books and magazines 
about the drug.  They all strongly support the anti-inflammatory action of the 
plant Mudakkatran.  
 The chemical analysis of the drug showed the presence of sulphate, 
oxalate, zinc, Magnesium, Iron, Arsenic, Tannic acid, Unsaturated compound 
and albumin. 
 The Pharmacognostic study of the plant Cardiospermum halicacabum 
was done in the Central Research Institute for Siddha, Chennai. 
 Anti microbial effects and pharmacological action of Mudakkatran plant 
were done in Vel's College of Pharmacy, Pallavaram, Chennai. 
 The anti-inflammatory and analgesic activity of the drug was studied and 
compared.  In the Cotton pouch granuloma test significant anti inflammatory 
activity was exerted by the Mudakkatran Chooranam. 
 For clinical trial 40 patients of both sex diagnosed as Vali Azhal 
Keelvayu according to siddha aspect and also with support of laboratory 
investigations and radiological findings. 
 The drug Mudakkatran Chooranam was given to the patients at the dose 
of 1 gm. with hot water, thrice daily after food for a maximum period of 70 days. 
 The prognosis was observed with keen interest and noted accordingly.  It 
is noted that in all patients the pain and swelling were reduced.  Other clinical 
symptoms were also gradually reduced. 
 The routine investigation of blood, urine, X-Ray were done after 
treatment. 
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 The suvai of Mudakkatran is Thuvarppu.  Thuvarppu suvai is made by the 
combination of the elements Mann (Earth) and Vali (Air).  It also possesses 
Veppa veeriyam.  In siddha maruthuvanga surukkam, it is said that veppa 
veerium reduces the diseases caused by Vatham.  So the selected drug reduces 
the pain and inflammation. 
 Out of 40 patients, 
• Good response was observed in 30 patients. 
• Moderate response in 8 cases. 
• Mild response in 2 cases. 
 All the above studies of Mudakkatran Chooranam give a clear picture of 
its efficacy in the treatment of Vali Azhal Keelvayu. 
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SUMMARY  
 Mudakkatran is a well known plant to us.  Whole plant of this herb was 
used in the form of chooranam.  The taste is thuvarppu. 
 The literary collection describes the anti-inflammatory and analgesic 
activity of Mudakkatran. 
 Botanical aspect deals with the identification description, cultivation, 
collection and ethno medical importance of the plant. 
 Gunapadam aspect expressed that the drug possess good anti vatha 
property. 
 The chemical analysis revealed that the Mudakkatran chooranam has 
sulphate, oxalate, zinc, magnesium, Arsenic, Iron, Tannic acid, unsaturated 
compound and albumin. 
 Pharmacological studies showed that the drug has significant anti-
inflammatory and analgesic activity. 
 In clinical study the drug has showed good response in 75% of cases.  
The patients were responding well from the begining of the treatment and no 
adverse effects were reported. 
 The present study suggests that Mudakkatran has the remarkable 
medicinal value for the disease Vali Azhal Keelvayu. 
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CONCLUSION 
 
 The trial drug "Mudakkatran" has been selected and its efficacy was 
analysed in the treatment of Vali Azhal Keelvayu. 
• Mudakkatran is a very easily available drug. 
• Preparation of the drug is very very economical 
• This selected drug has got significant anti inflammatory and 
analgesic effect. 
• Clinical studies revealed that the drug has effective and good 
response in 75% of the cases, moderate response in 20% of the 
cases.   
• So this present study about the herb Mudakkatran gives a new 
hope in the field of Vali Azhal Keelvayu treatment. 
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INTRODUCTION 
 
 The therapeutic system of Tamizhians is one of the oldest system of 
medicine dating upto 5000 years.  The ancient tamils made an insight into 
themselves in search of longevity. They developed two ways by which they 
achieved mastery over nature. 
 The one is YOGIC WAY 
 And the other is THROUGH MEDICINE 
 These scholars were called siddhars.  Hence the therapeutic system 
propagated by them is also known as "Siddha system of Medicine". 
 Siddha system emphasis a harmonious blending of physical, mental, 
social, moral and spiritual welfare of an individual. 
 Siddha system considers body as a whole of five elements viz., "Mann", 
"Neer", "Thee", "Vali", "Akayam".  These are the fundamental principles of 
creation, protection and destruction of the world.  The forces behind the three  
are respectively referred to as vatham, pitham, kapham in the case of human 
body.  In a healthy person the respective ratio is 1:1/2:1/4.  Any imbalance in 
this ratio can cause disease. 
 Nowadays people are getting too very stressed in order to keep in pace 
with the modern life style.  Modern life style seems to be equally attractive and 
destructive in different views.  In one view, advanced and sophisticated lives 
may woo the people to live in destructive mechanical and stressful environment.  
Fortunately the advances in modern medicine provide good discoveries and 
innovations to solve the arising health ailments.  Despite these efforts some 
diseases seems to be not curable completely due to the nature of frequent 
recurrences and remissions. 
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 Adding fuel to the five, the advent of the fast foods, tinned food and the 
other junk ones are giving more trouble to the gastro intestinal tract.  Hence over 
straining of the gastro intestinal tract may lead to a lot of Acid peptic disorders, 
which is becoming a common disease of the world. 
 It is estimated that roughly 10% of the population is expected to develop 
peptic  ulcer disease during their life time and the percentage seems to be rising 
at an alarming rate. 
 By following the simple basic disciplines of habits and food laid down by 
our ancestors, the diseases of stress such as peptic ulcer disease can be prevented 
and even cured. 
 There are many drugs in Siddha, which prove good against peptic ulcer 
disease.  One of them, is PACHAI KARPOORATHI CHOORANAM, has a 
strong evidence in our siddha literature.  Hence I have chosen it as the "Trial 
drug" for my dissertation. 
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AIM AND OBJECTIVE 
Aim :   The aim of this disseration work is to prove the efficacy of PACHAI 
KARPOORATHI CHOORANAM to treat GUNMAM. 
Object :    Gunmam is one of the commenst disease in the gastro intestinal tract. 
 It is caused by excessive secretion of HCL / Pepsin, infection of 
Helicobacter pylori and also caused by stress and anxiety. 
 Dietary use of spicy food, coffee, tea and use of NSAID, alcohol, tobacco 
are major casuses of Gunmam. 
 The signs and symptoms of Gunmam is characterised by pain in the 
epigastric region, heart burn, abdominal discomfort, nausea and vomiting.  In 
Siddha literatures PACHAI KARPOORATHI CHOORNAM is mentioned for 
Gunmam. 
 So the author choose the anti-ulcer property of the pachai Karpoorathi 
Chooranam through the Bio-chemical analysis, pharmacological studies and 
clinical trials. 
 PACHAI KARPOORATHI CHOORANAM was studies in the following 
aspects: 
• Photo Chemical aspect 
• Gunapadam review 
• Bio-Chemical analysis 
• Microbiological study 
• Pharmacological study 
• Clinical trials 
• Bio Statistical study 
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REVIEW OF LITERATURE 
PHYTOCHEMICAL & GUNAPADAM ASPECT 
PACHAI KARPOORAM (BORNEO CAMPHOR) 
Phyto chemical review of borneo camphor: 
Botonical name : Dryobalanops aromatica Gaertnif. 
Synonyms name : Dryobalanops Camphora 
Family  : Dipterocarpaceae 
Distribution of the plant : 
 Sumatra, Malay penisula and Borneo 
Habitate : Large tree 
Leaves : Stipulate 
Flowers : Bisexual, perianth is pentamerous 
 A characteristic feature of this family is the presence of resin canals as 
welll as persistent calyx.  The tree is 50m, tall with reddish chocolate brown 
wood with large patterns. 
 Borneo camphor is found in cavities or fissures in the wood of 
Dryobelanops aromatica and is collected by scraping.  It occurs in white 
translucent masses and closely resembles true camphor from cinnamomum 
camphora in many respects. 
 It is distinguished from the latter in being heavier than water, not 
volatilizing at ordinary temperature and in possessing a characteristic pungent 
odour and burning taste. 
 It is used in the same manner as camphor in meidicine and perfumery, it 
is also employed in organic synthesis.  Borneo camphor is highly prized in 
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Indian Medicine.  It is converted into ordinary camphor by treatment with 
boiling nitric acid1. 
Actions : 
 Diaphoretic, Stimulant of skin, Cardiac Antiseptic, Expectorant, Sedative, 
Temporary Aphrodisiac, Narcotic. 
Properties and Uses : 
 It is very peculiant fragrant and penetrating odour bitter.  Pungent and 
aromatic taste.  It is extremely volatile and inuammable burning with a bright 
light and much smoke. 
 It is good in typhus, confluent small pox and all fevers and eruptions of 
typhoid class; also in measles, febrile delirium, whooping cough, hiccup, 
spasmodic asthma, hysteria, dysmenorrhoea, puerperal mania, chorea, epilepsy, 
acute rheumatism, myalgia, toothache, chronic bronchitis, diarrhoea, etc.  It is 
stimulant in prostration of fevers, sedative in delirium treatment and chordae.  It 
exhilarates in moderate doses and raises the pulse with producing febrile 
symptom. 
 It is given in doses of 3 to 10 grains in pills, powder and in emulsion.  
Sniffed upto the nostrils it relieves cold in the head. 
 In cases of spermatorrhoea, chordae, pruritic chronic rheumatism, pills of 
camphor and opium in the proportion of 3 grains of the former to half-grain of 
the latter taken at bed time are found to be very efficacious. 
 In uterine pains 6 to 8 grains pills are administered and the liniment of 
camphor is rubbed on the abdomen. 
 Three or four grains of camphor with an equal quantity of asafoetida and 
made into a pill and administered in asthma, insomnia and delirium gives much 
relief. 
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 Camphor liniments, simple and compound, prepared by dissolving 
camphor in olive oil or rectified spirit and which are used externally as 
stimulants and counter irritants, especially in rheumatic pains of joints and 
muscles. 
 Camphor liniment is used for relief of pain in muscular rheumatism, 
sprains, fibrositis and neuralgia.  It is also used as a cardiac stimulant. 
 The bark of the plant is used as sedative, spasmodic diaphoretic and 
anthelmintic.  The roots and leaves are used for hardness of spleen and liver. 
 Ethanolic extract (50%) of fruits showed antibacterial activity against 
several gram negative and gram positive bacteria. 
PHYTO CHEMISTRY 1,4 
Chemical Constituents : 
 d- borneol (C10H17OH) 
 Borneol 
 Camphene 
 Terpinol 
 Sequiterpene 
 Dryobalanone 
 The mature leaves and twigs from Assam yield an essential oil (1.8 - 
2.3% fresh wt basis) having the following physico - chemical constants.  Sp gr 
20o, 0.9526; N20/D, 1.4710; acid val, 7; ester val 18; and ester val after 
acytylation, 93.  The oil contains 1, 8 - cineol (69.6%) as major constituent 
presence of α - and β - terpineol, α - and β  - pinene, lemonene, camphene, and p 
cymene is also reported7. 
 Two alkaloids -1 aurolitsine (norboldine) and reticuline isolated as 
perchlorates from roots8. 
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 Sesquiterpeniods - 1 - α - y tangene, 1 - β-elemene, 1-β caryophyllene, 
hulhumulene, selinene and d - nerodidol from leaf oil and twigs.9 
 Two new sesquiterpeniods - camphorenone and camphorenol from 
essential oil.10 
  High boiling fraction of camphor oil contained sesquiterpene - α - 
ylangene, β - santalene, δ - guainene, δ - Cadinene, Calamenene, Calacorene, η - 
Patchoulene and 1,6 - dimethyl 4 - isopropyl 7,8 - dihydronaphthalene9. 
g¢ir f‰óu« -  BORNEO CAMPHOR58 
 g¢ir f‰óu« fhurhu« ïUg¤ijªJ tifÆDŸ x‹whF«.  ïJ 
ïa‰ifahfî«, bra‰ifahfî« »il¡fToaJ. 
ntWbga®fŸ : 
 g¢irf‰ óu¤â‹ bgaiu¡ nfS 
  gyifah« óukJ rªâuD¡fhF« 
 c¢ir¡f©Ù uh¡»íij ghÉ¡fŠá 
  c©ikah§ fjÈí¥ò kâóukhnk 
 bfh¢ir kj‹ rÇahF§ FUî¡fhF« 
  bfhojhd K¡f©Â byhU f©zhF« 
 f¢irah« gonrhk‹ Ójs khndh‹ 
  f®¥óu bk‹nwng®fU thŒ¥ghnu50 
 
 ïkthYf«, fjÈí¥ò, bfs¤â g¢ir, rá, rªâu‹, nrhkD¥ò, 
Ójs«, Ójf‰óu«, g¢irôu«, gÈif, gh®kf‹ rhÇ, óu«, kâ, kUthË, 
Éªj«, ÉuÈ¥g¢ir, ïuÉ fŠá, g¢ir fdrhu«. 
g¢ir f‰óu¤âš _‹W tiffŸ cŸsd. mit, 
 1.  <r‹ 2.  åk‹ 3.  ójh¢áiwa‹ 
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<r‹ Fz« : 
 "<rbd‹D« óubt©ik ba‹guJ fhuKkh« 
 ngrÇa ÓjKZz« ã¤jkaš - åR»‹w 
 ÕÃrK£ lh»ait ngh®¤JÉL§ fhªâí© 
 lhd jhJtáa kh«" 
bghUŸ : 
 <r‹ v‹D« g¢ir f‰óu«, btS¥ò, jsjs¥ò fhu« cilaJ.  
fgRu«, ã¤j«, ka¡f«, ehánehŒ, jhfnuhf«, M»aitfis ngh¡F« 
táa¤J¡fhF«. 
åk‹ Fz« : 
 "åkbd‹D§ f‰óu« nkftG¡F bt©ik 
 nrkKW§ FË®¢á â‹w¡fh - dhkUî 
 nehafYª jhfkfY« E©ng âíkhUª 
 öa kâKfªjhŒ brhš" 
bghUŸ : 
 mG¡F bt©ik fyªj nkf ÃwKŸs åkdhš eh¡F KŸ, 
jfhnuhf« Ú§F«.  njf eyK« FË®¢áí« m‰g ÉnurdK« c©lh«. 
ójh¢áiwa‹ Fz« : 
 "ójh¢ áiwabdD« óukŠrŸ if¥ghF§ 
 nfhija®¡fh§ fhr§bfhL nkf« thjhâ 
 v‹Dª jÅ¤njhl nkWK¤njhlŠ brh¿í§ 
 F‹d ÉuzK« ngh¡F«" 
bghUŸ : 
 kŠrŸ ÃwK« if¥ò¢ RitíŸs ójh¢ áiwadhš ïUkš, 
mÇ¤âuh nkf«, thjã¤j fg njhl§fŸ, âÇnjhl«,eik, beU§»a 
ò©fŸ M»ad Ú§F«. 
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g¢ir f‰óu¤â‹ bghJFz« : 
 "m£lF‹kŠ Niy aQfhJ thjbkhL 
 J£lnkf¥ ãÂíª njh‰whnj - k£lyU§ 
 TªjYil khnj bfhoafg« nghFŠ 
 rh®g¢ir¡ f®¥óu¤jhš" 
bghUŸ : 
 g¢ir f‰óu¤jhš v©Éj F‹k§fŸ ÑšfËš F¤jš, thjnehŒ, 
Óœãunkf«, bfhoa fg« Ú§F«. 
g¢ir f‰óu k»ik 61 
 ghbu‹w óu¤â‹ gUt« nfS 
  gh§fhd f®¥óu thiH¡ FŸns 
 óbu‹w bghYbghyd¥ bghUÄ Ã‰F« 
  bgU§fh‰iw¡ f©lJnk gwªJ nghF« 
 nebu‹w Ú®ky«nghš vÇªJ nghF« 
  neuhf ïij vL¤J Äs»£L 
 thbu‹w thiHÆiy Ñœnkš ï£L 
  tskhf bg£o¡FŸ kUÉitna 
 
• fU¥óu thiH¡FŸns bghybghy vd bghUÄ Ã‰F«. 
• bgU§fh‰¿š gwªJ nghF«. 
• F‰wÄšyhj f©ÂÈ£lhš fiuªJ nghF« 
• cnyhf§fis mÇ¤JnghF«. 
• MÉg£lhš khakhF«. 
• thridí« FË®¢áíKilaJ. 
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g¢ir f‰óu it¥ò : 47 
 fhz¥gh ï‹dbkhU it¥ò nfS 
  fUthd óuklh g¢ir óu« 
 òz¥gh NlbdhUg yK«th§»¥ 
  òÅj KŸsbto¡ fh‰g yªjh‹ 
 njhz¥gh îtU¥ò¥ gyk iujh‹ T£o 
  JÇjKŸs òDFlnd Vyª jhD« 
 ntz¥gh fÞöÇt if¡F¤ jhD« 
  És§fnt aiufHŠR nt©L thna47 
bghUŸ : 
 Nl‹  - 1gy« 
 btoí¥ò - 1/4 gy« 
 f¿í¥ò - 1/2 gy« 
 òDF - 1/2 fHŠR 
 Vy« - 1/2 fHŠR 
 fÞöÇ - 1/2 fHŠR 
 nk‰T¿a ru¡Ffis fšt¤âÈ£L miu¤J ò£L nghy ãr¿ 
it¤J bfhŸs nt©L«.  öŒikahd fháF¥ãÆš miu¥g§F 
ï«kUªij kh¡fšyhš _oVG Óiyk© brŒa nt©L«.  ãwF xU 
jhÊÆš kzš ï£L mj‹ nkš ïªj¡ F¥ãia it¤J ã‹ò nkY« 
kzš ïlnt©L«.  jhÊ Ãiwa kzš ï£L nkš xL bfh©L _o 
VGÓiy k© brŒJ NÇa bt¥g¤âš fha it¤J fzgâia óá¤J 
thYifÆš V‰¿ xU rhk« Ôg«nghy vÇ¡fî«.  ãwF bkšy Mw it¤J 
FUtoia tz§» vL¤J gh®¡f nt©L«.  vL¤J¥ gh®¡ifÆny g¢ir 
f‰óukhdJ áWbghoahf jhkiu¥ó kz« cilajhf ïU¡F« mšyJ 
br§fGÚ® óÉid nghy kz« åR«. 
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g¢ir f‰óu it¥ò Kiw ÑœfhQ« üšfËY« Tw¥g£LŸsJ. 
 k¢rKÅ ehadh® fiyPhd« - 800 
 gjh®¤j Fz És¡f« 
g¢ir¡ f‰óukhdJ Mfhaój¢ ru¡F v‹gij , 
 "ÉÇªJ gh® óuKl‹ tHiy jhD« 
 nkyhd Mfhr¡ TWkh¢R" 
v‹w nghf® fhurhu¤ âu£oš Tw¥g£l bjhlÇdhš m¿ayh«. 
e£ò ru¡F, gif ru¡F : 
 "Ód¤J¡ »dnk òu«" 
 "óu¤jhš ïÈ§f« rhF«" 
v‹w bjhl®fËdhš g¢ir f‰óu¤â‹ e£ò¢ ru¡F - Ód«, gif¢ru¡F - 
ïÈ§f« v‹W« m¿ayh«. 
Rit :  if¥ò, c¥ò 
åÇa« :  ÓjåÇa« 
brŒif : 
 FË®¢áí©lh¡» 
 clš cukh¡» 
 nfhiHaf‰¿ 
 rkdfhÇ 
msî :  8 - 162 Ä.». tiu 
cgnahf§fŸ : 
1.   g¢ir f‰óu«, F§Fk¥ó, bt‰¿iy¡ fh«ò ïitfis miu¤J 
jhŒghÈš fyªJ JÂÆš eid¤J RunehÆdU¡F be‰¿ÆÈl 
RuªjÂí«. 
2.   g¢ir f‰óu« miu mÇá (32 Ä.».) vilia xU gy« rªjd 
FH«ãš fyªJ nkY¡F cgnah»¡f m~J clY¡F FË®¢áia 
jªJ áu§F, nfhilÆš c©lhF« Éa®it, clš vÇ¢rš 
KjÈat‰iw Ú¡F«.  cŸS¡F ju btŸis nehŒ ÔU«. 
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3.   g©ila ehËš jhJ ÉU¤â¡fhf¥ g¢ir¡ f‰óu¤ij 
c£bfh©lij, 
 "fokhiy No fU¥óu K¡».... 
 bjhilkhiy bk‹Kiyah® njhlhŒªJ ikªj®" 
      (áªjhkÂ 1574) 
v‹w moahš m¿ayh«. 
4.  g¢ir f‰óu«, fÞöÇ ïu©ilí« fyªJ bt¥gK©lh¡» 
brŒif¡fhfî«, fgthjRu«, fhr«, Rthrfhr«, KjÈa Eiupuš 
g‰¿a nehŒfS¡F« cgnah»¡fyh«. 
5.   g¢ir f‰óu« 5»uh« vL¤J 100 ÄÈ v©bzÆš fyªJ fhŒ¢á 
Nlh¡», thjtÈ, _£LtÈ¡F btË¥ãunahfkhf 
cgnah»¡fyh«. 
g¢ir f‰óu« nrU« F‹knehŒ Ô®¡F« kUªJfŸ : 
1.  f‰óuhâ Nuz«21 
 g¢ir f‰óu« 
 óyh¡»H§F 
 Vy«    rkmsî 
 rhâ¡fhŒ 
 rhâg¤âÇ 
 »uh«ò  - 35 »uh« 
 áWehf¥ó  - 35 »uh« 
 ÄsF   - 105 »uh« 
 â¥ãÈ  - 140 »uh« 
 áW_y«  - 175 »uh« 
 ïªJ¥ò  - 210 »uh« 
 R¡F   - 245 »uh« 
 ïitfis bgho brŒJ bfh©L ÓÅ r®¡fiu rkkhŒ T£o 
njÅš c©zîk. 
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ÔU« ãÂfŸ ; 
 Rthrfhr«, _y«, F‹k«, vÇ¢rš, x¡fhs«, beŠril¥ò 
2.  nkfuh#h§f ïsf«23 
3.  thj¤J¡F mKj r®¡fiu57 
4.  eªâ bkGF31 
5.  kfhtrªj FRkhfu kh¤âiu31 
g¢ir f‰óu« nrU« ãw kUªJfŸ : 
1.  kfhåu bkGF31 
2.  trªj FRkhfu kh¤âiu 31 
3.  kfhVyhâ FËif31 
4.  g¢ir f‰óu kh¤âiu31 
5.  nfhnuhrid kh¤âiu32 
6.  fÞöÇ fU¥ò31 
7.  ïsÚ® FH«ò33 
8.  ÄUJthâ¡FH«ò24 
9.  g¢ir f‰óu R©z«25 
10.  ïurf‰óu g‰g«56 
11.  ïoóuzhâ ïsf«39 
12.  ïUkš kh¤âiu31 
13.  g¢ir f‰óu bgho58 
14.  g¢ir f‰óu mŠrd FËif58 
15.  mÄ®j rŠÓÉ FËif56 
16.  g¢ir f‰óu cU©il56 
17.  Éndhj rŠÓÉ kh¤âiu56 
18.  g¢ir f‰óu braÚ®25 
19.  nfhnuhrid¡ FËif32 
20.  nfhnuhrid kh¤âiu57 
21.  fÞöÇ bkGF58 
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22.  bgÇa rhâ r«Õu¡ FH«ò26 
23.  f‰óuhâ ïsf«56 
24. gŠrNj bkGF56 
25.  g¢ir f‰óu bkGF56 
26.  âuh£ir beŒ56 
27.  nfhnuhrid bkGF56 
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Myristica fragrans  Houtt. 
Vernacular name 2 : 
 Sans - Jati-phalam 
 Eng - Nut meg 
 Hind - Jaepatri 
 Pun - Jayiphal 
 Tel - Jajikaya 
 Tam - Jadikkay 
 Mal - Jatika 
 Arab - Sauz - bawwa 
Part Used : Nut meg. 
History and Distribution5 : 
 A native of Molluccas, cultivated in many tropical countries.  Grown in 
Kerala, Karnataka.  The Nilgiris and West Bengal. 
Phyto Chemistry62 : 
 Myristicin, C11H12O3, constituting 4 per cent of the oil is interesting as the 
fraction responsible for many of the pharmacological effects Chemically, 
myristicin resembles three other aromatic ether components of Myristica oil : 
eugenol, isoeugenol, and safrolof nutmeg and mace. 
Chemical Composition1 : 
 Moisture - 14.3 Phosphorous - 0.24% 
 Protein - 7.5 Iron  - 4.6 mg/ 100 g 
 Ether extr. - 36.4 Volatile oil - 6-16% 
 Carbo hydrate - 28.5 Starch  - 14.6 - 24.2% 
 Fibre  - 11.6 Pentosans - 2.25% 
 Mineral matter - 1.7% Furfural - 1.5% 
     Pectin  - 0.5 - 0.6% 
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Medicinal Uses1,62 : 
• Nut meg is stimulant, carminative, Astringent and Aphrodisiac. 
• It is used in tonics and electuaries and forms a constituent of 
preperations prescribed for dysentery, stomach ache, flatulence, 
nausea, vomiting, malaria, rheumatism and sciatica and early 
stages of leprosy. 
• Arab physicians seem to have used nutmeg as a drug from the 
first centuries A.D., although just how they used it is not known.  
Myristica  was recommended for a variety of disorders in this 
early period but was taken mainly for diseases of the digestive 
organs from the mouth to the stomach to the intestines, to the 
liver and spleen, as well as for freckles and skin blotches. 
rhâ¡fhŒ - NUT MEG 
ntWbga® : Fy¡fhŒ 
 rhâ¡fhÆ‹ ng®jidna rh‰w¡nfS 
  rhâa yŠrâ¢ áaKkhF 
 khâ¡fhŒ rhÿu«khš Ôgykh« 
  kjrî© lŠrhâ NfkKkhF« 
 fhâ¡fhŒ f¥ãÈÜ Jiu¢áahF« 
  fL¡fhÆ‹ »Çjh‹gš yH» 
 Nâ¡fhŒ »u¡fÂ ã¤jdhFŠ 
  br¥ãdnjh® rhâ¡fhŒ¥ ngUkhnk50 
Rit :  Jt®¥ò, fh®¥ò 
j‹ik :  bt¥g« 
ãÇî :  fh®¥ò 
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brŒif : 
 bt¥gK©lh¡» 
 mf£LthŒtf‰¿ 
 _®¢irí©lh¡»  
 kz_£o 
 fhk«bgU¡» 
 cukh¡» 
bghJFz« : 
 jhJ e£l« ngâ rUthá aŠáu nehŒ 
 xJRth r§fhr« c£»uhÂ - ntnjh 
 oy¡fhŒ tU«ãÂngh« V‰wkaš ã¤j§ 
 Fy¡fh aUªJth®¡F¡ TW   (mf¤âa® Fzthfl«) 
bghUŸ : 
 ÉªJ Fiwî, bgU§fÊ¢rš, jiytÈ, ïiu¥ò, ïUkš, eh£g£l 
fÊ¢rš, bt¥g¥ ãÂfŸ ït‰iw ngh¡F«.  Mdhš ka¡f¤ij jU«.  
tÆ‰WtÈ, tÆ‰W bghUkš, m¡»Å kªj« ïitfis ngh¡F«. 
tH§F« msî :  320 - 1000 Ä.». 
rhâ¡fhŒ nrU« F‹k« ngh¡F« kUªJfŸ : 
1.  F‹k¤J¡F kUªJ27 
 F§»Èa«, nt¥g«g£il, Óªâšj©L, f©l§f¤âÇ, Vy¡fhŒ, 
rhâ¡fhŒ, thYSit, mu¤ij, R¡F, bfhJkšÈ, »uh«ò, mâkJu«, 
bfhontÈ, ÄsF  - ïit mid¤J« jyh 2 thuf‹ vil 
r®¡fiu  - 5 gy« 
nj‹  - 5 gy« 
gRbeŒ - 2 1/2 gy« 
 nj‹ k‰W« beŒ ïitfis¤ jÉu k‰wij ïo¤J NuÂ¤J¡ 
bfhŸsî«.  r®¡fiuia¥ ghFbrŒJ Nuz¤ijí« bfh£o ãwF nj‹, 
beŒ nr®¤J g¡FtŠ brŒJ bfhŸsî«. 
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msî :  fH‰áasî, ïUntis 
ÔU« ãÂ :  beŠRtÈ, tÆ‰W Niy, F‹k«, mârhu«. 
2. jhËr g¤âÇ Nuz«39 
3.  fªjf urhad«34 
4.  eªâ ik31 
5.  ehu¤ij ïsf«35 
6.  Éšthâ ïsf«36 
7.  nkfuhrh§f ïsf«23 
8.  f©l§f¤âÇ »Uj«32 
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Mesua ferrea Linn. 
Vernacular name2 : 
 Sans  - Nagkesara 
 Eng  - Cobra's saffron 
 French - Mesua Naghas 
 Hind  - Naga-kesara  
 Tel  - Naga shap-pu 
 Ben  - Nagesar 
 Tam  - Cheru-Nagapu 
 Mal  - Naga champakam 
 Arab  - Narae-Kaisar 
Part Used : 
 Fruits, seeds, flowers, leaves and bark. 
History and Distribution5 : 
 Find in the Eastern Himalayas, Assam, West Bengal, Eastern and 
Western Ghats as well the Andamans, Ascending to an elevation of 1500 m. 
Chemical Composition :1  
• Mesua seeds contain a pale yellow Lactone, Mesuol, Mesuone (has 
anti bacterial activity against micrococus pyogens) 
• Mesuol is more active than mesuone and activities of both are 
markedly depressed in the precence of normal serum. 
• Mesuol is an active as allicin and 0.1% as active as penicillin 'G' 
against M.pyogens. 
• Kernel meal freed from oil is rich in nitrogen and phosphorus. 
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Medicinal uses6 :  
• Flowers are Astringent, digestive, carminative, anthelmintic, 
stomachic, aphrodisiac and cardio tonic. 
• They are useful in asthma, cough, leprosy, scabies, skin diseases, 
vomiting, dysentery, haemorrhoids, ulcers, burning sensation of feet, 
leucorrhoea, haemoptysis, fever and cardiac debility. 
• The seed oil is used in skin diseases. 
• Leaves are applied to the head in severe cold. 
 
áWehf¥ó 
ntWbga® : 
 áWehf¥ óngiu¢ br¥g¡nfS 
  brakhd xkfhŠ rdKkhF« 
 eUehf¥ ò£ãa®¤j ò£ãahF« 
  ehf nrfukh _®¡fkhF« 
 jUehfŠ rh«ãa« eh¡»Šry¡f« 
  rh«óªj«  Mlf«Õj nrfukh« 
 cWehf« nahfnk r§nfahF« 
  ciu¤j áWehf¥ó î©ikahnk50 
bghUŸ :  ehf«, ehfò£g«, ehnfru«, nfru«, rh«ngag« 
Rit :  áWif¥ò, Jt®¥ò 
j‹ik:  j£g« 
ãÇî : fh®¥ò 
brŒif :  Jt®¥ã, mf£LthŒtf‰¿, kz_£o 
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bghJFz« :   
 áWehf¥ óÉdJ brŒifjid¢ brhšnth« 
 F¿ahF« nkf¤ij¡ bfhšY« - be¿É£L¤ 
 ÔjhŒ¢ bršthíitíª Ô®¡FÄF k‰ngh¡F« 
 nfhjhŒ ! ïija¿ªJ bfhŸ. 
bghUŸ : 
btŸis, ïUkš, fÊ¢rš, Úuil¥ò, FUâ¥ngh¡F, ò©, 
bfh¥òs«, fhbyÇ¢rš KjÈad ngh¡F«. 
áWehf¥ó nrU« F‹k« ngh¡F« kUªJfŸ : 
1.  mK¡»uh Nuz«32 
2.  fªjfurhad«34 
3.  jhËrhâ Nuz«31 
4.  ehu¤ij ïsf«35 
5.  Éšthâ ïsf«36 
6.  kfhVyhâ Nuz«52 
7.  nkfuhrh§f ïsf«23 
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Cinnamomum zeylanicum Breyn. 
Vernacular Name5 
 Sans  - Tvacha 
 Hindi  - Tvakh 
 Beng  - Daruchini 
 Tam  - Ilavanga Pattai 
 Eng  - Cinnamon 
Part Used  :  Bark 
History and Distribution5 : 
 Found wild in the southern costal region of western India upto elevation 
of 1828 m.  Abudant in the regions 30 - 215 m above the sea level fairly 
common upto 1100 m. 
Chemical Constituents1 : 
• Aqueous extract of bark showed significant anti allergic activity in 
geunea pig. 
• The extracts also shows potent antiulcerogenic activity in rats and is 
comparable in a activity with cimetidine. 
• Anti ulcerogenic compounds have been isolated from bark. 
• Cassioside (C20H32O9) 
• Cinnamoside (C24H38O12) 
• 3,4,5 tri methoxyphenol 
   β - D - apiofuranosyl 
   β-D-Glucopyranoside 
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Medicinal Uses5 : 
• The dried inner bark constitutes the drug, used in diarrhoea, nausea and 
vomiting. 
• Oil obtained from bark is used as a stomachic and carmintive.  It cures 
gastric debility and flatulence.  It is germicide and fungicide as well. 
ïyt§f¥ g£il 
ntWbga® :  fUth¥g£il 
Rit :  fh®¥ò, ïÅ¥ò 
j‹ik : j£g«, bt¥g« 
ãÇî : ïÅ¥ò, fh®¥ò 
brŒif : bt¥gK©lh¡», mf£LthŒtf‰¿, fhk«bgU¡» 
bghJFz« : 
 jhJe£l« ngâ rUtÉõ« M»anehŒ 
 ój»u fŠáy¤â¥ ó¢áÉlŠ - rhâÉl« 
 M£LÄiu¥ bghoUkš M»anehŒ¡ T£lkw 
 X£LÄy t§f¤ JÇ 
 r‹dyt§ f¥g£il jh‹FË®¢á í©lh¡F« 
 ï‹DÄu¤ j¡fL¥ig p®¡F§fh© - K‹dKW« 
 cªâ¡ fL¥gf‰W« C©_y¥ ò©ngh¡F« 
 fªjÄF ó§FHny ! fh©. 
bghUŸ : 
gh«òfo, áyªâó¢á¡fo, KjÈaitfË‹ eŠir¥ ngh¡F«.  
ï~J ïiu¥ò, ïUkš, tÆ‰W¡ fL¥ò, cŸ_y¥ò© 
KjÈat‰iw¥ ngh¡F«.  cl‰F¡ FË®¢áia c©L g©Q«. 
tH§F« msî :  65 - 260 Ä.». 
ïyt§f¥g£il nrU« F‹k« ngh¡F« kUªJfŸ : 
1.  fªjf urhaz«34 
2.  ruò§f Éšthâ ïsf«32 
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3.  jhËrhâ Nuz«31 
4.  Éšthâ ïsf«36 
5.  nkfuhrh§f ïsf«23 
 
Cinnamomum tamala Nees & Eberm 
Vernacular names5 : 
 Sans  - Patraka 
 Hind  - Tejpata 
 Eng  - Indian Cassia 
Part Used :  Leaves 
History and Distribution5 : 
 Found in tropical and sub-tropical Himalayas (900 - 2500 m) and Khasi 
and Jaintia hills (900 - 1200 m) 
Chemical Constituents1: 
• d - α - phelladrene 
• eugenol 
• Cinnamic aldehyde 
Medicinal Uses : 
 Leaves used as carminative in colic and diarrhoea. 
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ïyt§f g¤âÇ 
ntW bga® :  jkhy¥g¤âÇ, jhËrg¤âÇ 
Rit : fh®¥ò 
åÇa« :  bt¥g« 
ãÇî :  fh®¥ò 
brŒif :   
bt¥gK©lh¡», mf£LthŒtf‰¿, gá¤Ô¤ö©o, Éa®it 
bgU¡» 
bghJFz« : 
nkfRu« ÓjRu« bt£ilRth r§fhr« 
jhfã¤j« thªâr® tháanehŒ - nkf¤â‹ 
f£obahL jhJe£ghŒ if¥gUá ngh¡»ÉL« 
ï£lïy t§f¤ âiy 
bghUŸ :   
 nkfRu«, IaRu«, bt£il, ïiu¥ò, ïUkš, Ú®nt£if, mHš, 
thªâ, thŒ¥ò©, nkf¡f£o, jhJe£l«, if¥òRit ïitfis 
ngh¡F«. 
ïyt§f¥g¤âÇ nrU« F‹k« ngh¡F« kUªJfŸ : 
1.  fªjf urhad«34 
2.  jhËrhâ Nuz«31 
3.  f‰óuhâ Nuz«28 
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Piper nigrum Linn. 
Vernacular name11 : 
 Beng  - Golmorich 
 Guj  - Kalmorich 
 Hind  - Kalimirch 
 Kan  - Kare menosu 
 Mal  - Kurumulaku 
 Tam  - Milagu 
 Tel  - Miriya Latige 
 Eng  - Black pepper 
Part Used :  Fruit 
History and Distribution11: 
 A climbing perennial shurb cultivated in the hotter and moist parts of 
India. 
Chemical composition11: 
 The major components of the oil are, 
• Sabinene 
• Myrcene 
• Limonene 
• α - & β - Pinenes 
• Caryophyllene 
• α - bergamotene 
• α - humulene 
• p - cymene 
• α - selinene 
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Medicinal uses : 
• Dried unripe fruits constitute the drug. 
• It is stimulant, carminative and stomachic. 
• The fruit is pungent, bitter, hot, anthelmintic  
• Useful in kapha and vatha, asthma, pains, disease of throat, piles, urinary 
discharges, night blindness; Brings on sleep and epileptic fits. 
• Useful in tooth ache, inflammation, pain in the liver and muscles, 
lumbago, leucoderma, chronic fevers and paralysis. 
ÄsF 
ntWbga® : 
Äs»Dl bga®jidna bkhÊa¡ nfS 
 Kâ®ªJÃ‹w âiungh¡» ÄÇáahF« 
ts»Dl tšyrkhª Ô£rzKkhF 
 kf¤jhd öÉdkh káakhF§ 
Fs»Dl KZzkh« g¤JtneZl§ 
 nfhsfkhŠ rugªj ÃâakhF« 
ts»Dl thj¤ij aW¡»‹w 
 kf¤jhd ÄsF¡F ehkkhnk50 
bghUŸ : 
fÈid, f¿, fha«, nfhsf«, âu§fš, ÄÇaš, rUkgªj«, tŸËr«, 
khkr«, FWÄsF, kiyahË 
Rit :  if¥ò, fh®¥ò 
j‹ik :  bt¥g« 
ãÇî :  fh®¥ò 
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brŒif : 
fhwY©lh¡» 
mf£LthŒtf‰¿ 
Kiwbt¥gf‰¿ 
jo¥ò©lh¡» 
bt¥gK©lh¡» 
å¡f§fiu¢á 
thjkl¡» 
e¢rÇ 
bghJFz« : 
ÓjRu« gh©L ány¤k§ »uhÂF‹k« 
thj« mUáã¤j« kh_y« - xJr‹Å 
ahrkgÞ khu« ml‹nkf« fhrÄit 
ehr§ f¿Äs»dhš    
     (mf¤âa® Fzthfl«) 
 
nfhQ»‹w g¡ftÈ FŒaînuh f«thj 
nrhÂj§f K¤â‰FŸ njh‹WnehŒ - fhzÇa 
fhJnehŒ khj®F‹k§ fhkhiy kªjbk‹Ö® 
VJnehŒ fhÆU¡»š <§F 
    (njiua® Fzthfl«) 
bghUŸ : 
FË®Ru«, gh©L, nfhiH, fÊ¢rš, F‹k«, thí, RitÆ‹ik, 
bt¿, _y«, r‹Åahr«, mgÞkhu«, ãunkf«, ïUkš, g¡fthj«, 
FŒanuhf«, nrhÂjthj«, fsnehŒ, brÉtÈ, ïu¤jF‹k«, 
brÇahik, fhkhiy ïit nghF«. 
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Äs»‹ bgUik  
ÄsF, tË, Ô, fgF‰w§fŸ ïit mid¤ijí« Ú¡F«.  m‹¿í« 
âÄ®thj«, fHiy, tË, rË ïitfisí« mf‰W«. 
       (nju‹ bt©gh) 
ÄsF nrU« F‹k« ngh¡F« kUªJfŸ  
1. ÄsF bgho  -  51 »uh« 
 Ú®  -  700 Ä.È. 
 ÄsF bghoia ÚÇÈ£L miukÂneu« fhŒ¢á tof£o, mâš 30 
- 60 ÄÈ åj« âd« ïUntis ju bjh©il f«kš, bjh©ilò© 
k‰W« tÆ‰iw¢ nr®ªj nehŒfS« Ú§F«.51 
2.   ÄsF, R¡F, â¥ãÈ, nrh«ò, ghiwc¥ò ïitfŸ X® msthf¢ 
nr®¤J bgho brŒJ 2 - 4 »uh«, czî¡F ã‹ thÆÈ£L bk‹W 
ÉG§f, brÇ¥ig ãw¥ã¤J tÆ‰W nehiaí« ngh¡F«. 
3.   R¡F 
 ÄsF 
 â¥ãÈ 
 mâÉla«   ïit mid¤J« jyh 1 gy« 
 áWehf¥ó 
 ïyt§f¥g£il 
 rhâ¡fhŒ 
 rhâg¤âÇ 
 Xk«      
 R©il t‰wš  1/2 gy« 
 bgU§fha«   1/2 gy« 
 cy®ªj ãu©il  2 gy« 
 ïªJ¥ò   1 á£oif 
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 nk‰go ru¡FfËš ïªJ¥ig jÉu k‰w ru¡Ffis bgho¤J 2 go 
Ú® É£L 8š 1 g§fhf fhŒ¢á to¤J 1/2 MH¡F FoÚÇš ïªJ¥ò 
bghoia¢ nr®¤J fhiy khiy bfhL¡f F‹k¡ fÊ¢rš ÔU«.29 
4.  mK¡»uh Nuz«32 
5.  jhËrhâ Nuz«31 
6.  âuh£rhâ Nuz«41 
7.  fªjfurhaz«34 
8.  Fk£o¡FH«ò35 
9.  F‹kFnlhÇ bkGF31 
10.  átdh® mÄ®j«31 
11.  etc¥ò bkGF31 
br›Éa«51 - Black Pepper Root 
ntWbga® 
br›Éa¤â‹ bga®jidna br¥g¡nfS 
 br›Éfkh§ nfhytš ärkhF« 
m›Éakh§ bfªjhfh bfhÈíkhF« 
 M®¡fkh§ f©Ou§ f^õÂahFŠ 
á›Éakhª âÄuf¤J kÔudhFŠ 
 ány£L k¤ij¥ ngh¡F»‹w âwkhdhF« 
t›Éakh« tªjnfhg rkÅahF« 
 tF¤Jiu¤J br›Éa¤â‹ ngUkhnk50 
bghUŸ :  f©Oiu, rÉif, rÉa«, Äs»‹nt® 
bghJFz« : 
Niy mU»r‹Å bjhšÈUkš <isã¤j« 
nkiy¡ Fu‰f«kš bt§fsnehŒ - _yRu« 
f›Éa§f¤ njW fdjh tuÉlKŠ 
br›Éa§ bfhŸs ÉLª nj® 
      (mf¤âa® Fzthfl«) 
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bghUŸ : 
 ïJ Äs»‹ ntuhF«.  Äs»‹ Fz§fŸ ïj‰F©L.  Mdhš 
Äs»‹ fhu« ïj‰F »ilahJ. 
 br›Éa¤jhš Niy, RitÆ‹ik, K¥ãÂ, eh£g£l Ru«, Úo¤j 
ïUkš, <is, btË, Fu‰f«kš, bjh©il nehŒ, Ru«, vY«ig¥g‰¿ 
VW»‹w eŠR KjÈad nghF«. 
 
br›Éa« nrU« F‹k« ngh¡F« kUªJfŸ : 
1.  eªâ ik31 
2.  ghtd fL¡fhŒ38 
 
Illicium Verum Hook  
Vernacular name1: 
 Hind  - Anasphal 
 Tel  - Anaspuvu 
 Tam  - Takkolam, Anasi-pu 
 Bombay - Badian 
 Eng  - Star anise 
Part Used :  Fruit 
History and Distribution:1 
 It does not occur in India.  But it's fruits imported from China and Indo-
China.  It is an evergreen tree attaining a height of 8 - 15 m. 
Phyto Chemistry : 
 Shikimic Acid is an monomer which is extracted from Illicium verum 
Hook. f., Shikimic Acid is a key precursor of many alkaloids, aromatic amino 
acids, indole derivatives.  Chinese herb Star Anise (Illicium verum Hook.f.) have 
been used in Chinese medicine for centuries, instead of normal used to flavour 
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ingredients, it also have been widely used for the treatment of indigestion, 
stomach ache, colic in babies, and even facial paralysis, in recently years, 
scientists also have found that star anise has possible cancer-fighting 
properties63. 
Medicinal uses : 
• Star anise plant is used for flavouring foods and confectionary. 
• It is considered useful for Colic, constipation and insomnia. 
• It is given for the treatment of indigestion, loss of appetite. 
• Oil of the frutit if applied to the abdomen of the children, it relieves the 
pain resulting accumulation of gas in the alimentary canal. 
• The dried flowers are used to cheek vomiting. 
 
j¡nfhy« - Annasippu51 
Rit :  ïÅ¥ò, ÉWÉW¥ò 
j‹ik : bt¥g« 
ãÇî : fh®¥ò 
brŒif :  gá¤Ôö©o, bt¥gK©lh¡», cukh¡» 
Fz« : 
 ïJ brÇahik, khªj«, t‹ik¡Fiwî KjÈa nehŒfis¥ 
ngh¡F«. 
j¡nfhy« nrU« kUªJfŸ : 
1. f‰óuhâ Nuz« : 
f‰óuª j¡nfhyŠ rhâ¡fhÆš 
 t§fÆiy »uh«ò R¡FŠ 
brh‰bgÇa ÄsFl‹ bt›ÉaK§ Tl¢ 
 Rfkhf bth›bth‹W Éuhfbdil MwhŒ 
k‰goa ösh¡»¢ r®¡fiu njÅ‰bfhŸs 
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 kh¿ÉL§ F‹kra« tUªjhbj‹d 
J‰ght§ f‰óuhâ Nuz¤â‹ nrâ 
 brh‹dgo brŒaKÅ brhšY»‹whnw28 
bghUŸ :  
 f‰óu«, rhâ¡fhŒ, j¡nfhy«, ÄsF, br›Éa«, ïyt§f g¤âÇ, 
R¡F, »uh«ò ïitfis tif¡F 6 tuhfbdil åj« vL¤J ïo¤J 
tÞâufhaŠ brŒJ, Nuz¤ij nj‹ mšyJ r®¡fiu¡ T£o 
c£bfhŸsî«. 
ÔU« ãÂfŸ :  ra«, F‹k« 
2.  f‰óuhâ FËif30 
3.  fªjf urhad«34 
4.  ïyF rªjdhâ ijy«37 
5.  bešÈ¡fhŒ ïsf«43 
6.  gw§»¥g£il urhad«32 
7.  tšyhiu beŒ44 
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Saccharum officinarum Linn. 
 Sans  - Ikshu 
 Hind  - Pundia 
 Tel  - Cheruku 
 Tam  - Karumbu 
 Kan  - Khabbu 
 Mal  - Karinpa 
Part Used :  Sugar 
Chemical Constituents 4 : 
• A non-source portion of juice from stalks markedly reduce blood sugar 
level in mice. 
• Six glycans - saccharans A,B,C D & F isolated from hypoglycaemic 
fraction of stalk juice, neocarlinoside; neoisochaftoside; orientin; 
vincenin-2 and p - coumaric, ferulic, caffaeric and 3,4 di -0- methyl 
caffaeric acids isolated. 
Properties and Uses3 : 
• The stems are cooling, emollient, laxactive, cardiac tonic, diuretic, 
galactogague, aphrodisiac, expectorant, haemostatic and tonic. 
• They are useful in fatigue, leprosy, gastropathy, cardiac debility, cough, 
bronchitis, anaemia, ulcers of the skin and mucus membrane, general 
debility. 
• In cambodia, sugarcane enters into the composition of remedies used for 
the treatment of ulcers of the skin and mucusmembrane. 
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rU¡fiu - Sugar51 
Rit :  ïÅ¥ò 
j‹ik :  j£g« 
ãÇî :  ïÅ¥ò 
brŒif: mGfyf‰¿, cŸsHyh‰¿ 
bghJFz« : 
ÓÅrU¡ fiu¡F¤ Ôuhj t‹ruK§ 
TÅ¡F« thj¤â‹ T£Lwî« - VÅ‰F« 
thªâ bahL »UÄ khwhj É¡fYnk 
nghªâiria É£L òu©L 
     (mf¤âa® Fzthfl«) 
bghUŸ : 
 ïjdhš thjRu«, thªâ, E©òG, É¡fš ïitfis ngh¡F«. 
 
»Ëôuš g£il51 - Kiliyuram bark 
Rit :  if¥ò 
j‹ik :  j£g« 
ãÇî :  fh®¥ò 
brŒif :  FË®¢áí©lh¡» 
bghJFz« 
kztU¡f khF« tURu¤ij¥ ngh¡Fª 
jzyha bt¥ig¤ jÂ¡F§ - Fzkh® 
»Ëôu‰ g£ilaJ Ñj« gÆY 
kËôU« ó§FHny ahŒ60 
bghUŸ :   
 bt¥g¤ij jÂ¡F«.  bt¥g«, Ru« KjÈaitfis ngh¡F«. 
»Ëôuš g£il nrU« kUªJ : 
1.  mu¡F ijy«37 
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MATERIALS AND METHODS 
 
Prepation of the Trial Drug 
 The ingredients of Pachai karpoorathi chooranam are56, 
 1.  Borneo camphor  - 1 part 
 2.  Kiliyuram Bark  - 2 part 
 3.  Takkolam   - 5 part 
 4.  Nut meg   - 2 part 
 5.  Lavanga pathiri  - 5 part 
 6.  Cinnamon Bark  - 8 part 
 7.  Chiru - nagappu  - 7 part 
 8.  Black pepper   - 8 part 
 9.  Black pepper root - 9 part 
 10. Cane sugar  - 45 part 
Collection of Drug : 
 The above 10 raw drugs were bought from the raw drug shop in Chennai 
and were identified by siddha faculty, Gunapadam Dept., G.S.M.C., Chennai. 
Purification of Drugs : 
1.  PACHAI KARPOORAM : 
 Soaked in the juice of Senguvalai flowers for 24 minutes.58 
2.  TAKKOLAM: 
 Kept under sunlight and made dried.39 
3.  NUT MEG : 
 The skin of the dried fruit was peeled out and fried in ghee48. 
4.  LAVANGA PATHIRI 
 Dried under sunlight39 
5.  CINNAMON BARK 
 Kept under the sunlight and made dried39. 
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6.  CHIRUNAGAPPU 
 Kept under sunlight and made dried39. 
7.  BLACK PEPPER 
 Soaked in the sour butter milk for 3 hours and made dried.39 
8.  BLACK PEPPER ROOT 
 The outer skin was removed and sliced into pieces and dried under 
sunlight39. 
Preparation of Drug : 
 Purified drugs were finely powdered.  Then it was sieved by a fine white 
cloth. 
Purification of Chooranam : 
 Purified by steam - cooking in milk (Pittavial method).  The same was 
later dried, powdered and sieved again and preserved. 
Preservation : 
 The purified chooranam was stored in an air tight glass container.  As the 
shelf - life of Chooranam is only three months,  it was used with in that period. 
Administration of the Drug  
 Route  : Enteral 
 Dose  : 2.1 gms, 3 times a day; Before food 
 Vehicle : Ghee 
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Figure 4 
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METHODOLOGY 
 
For the clinical trial 
1. Bio Chemical Analysis 
2. Antimicrobial study 
3. Pharmacological study 
4. Clinical Study 
5. Statistical analysis 
were done on the Pachai Karpoorathi Chooranam and the methods of analysis 
are as follows and the observation and results of the analysis are given in 
appropriate headings. 
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BIO-CHEMICAL ANALYSIS 
Preparation of  Extract 
 5 gm. of Pachai Karpoorathi Choornam was weighed accurately and 
placed in a 250 ml clean beaker and added with 50 ml of distilled water. Then it 
was boiled well for about 10 minutes. Then it was cooled and filtered in a 100 
ml volumetric flask and made upto 100 ml with distilled water. 
 
SI.No Experiment Observation Inference 
1. I. Test for Acid Radicals. 
1. Test for sulphate : 
  
I. a) 2 ml of  the above prepared extract 
was taken in a test tube. To this add 2 
ml of 4% Ammonium oxalate 
solution. 
Cloudy 
appearance white 
precipitate was 
obtained  
Presence of 
sulphate 
b) 2 ml of Sodium carbonate extract 
was added with 2 ml of dilute 
Hydrochioric acid was until the 
effervescence ceases off. Then 2 ml 
of Barium chloride solution was 
added. 
White precipitate 
insoluble in Con. 
Hcl was obtained 
Sulphate was 
confirmed 
II. Test for Chloride : 
2 ml of Sodium carbonate extract 
was added with dilute  Nitric acid till 
the effervescence ceases. Then 2 ml 
of Silver Nitrate solution was added. 
Cloudy white 
precipitate 
completely 
soluble in excess 
of Ammonium 
hydraxide solution 
was obtained. 
Chloride was 
confirmed 
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III. Test for Phospate : 
2 ml of  the extract was treated with 
2 ml of Ammonium Molybdate 
solution and 2 ml of concentrated 
Nitric acid. 
Presence of 
yellow precipitate  
Presence of 
phosphate 
IV. 5 drops of clear solution was added 
with 2 ml of dilute Sulphuric acid 
and slightly warmed. To this, 1 ml of 
dilute Potassium permanganate 
solution was added. 
KMnO4 solution 
was decolurised 
Presence of 
Oxalate. 
V. Test for Zinc: 
To the 2 ml of extract sodium 
hydroxide solution was added in 
drops to excess. 
White precipitate 
soluble in excess 
of NaoH was 
obtained. 
Zinc was 
confirmed. 
VI. Test for Calcium : 
2 ml of  the extract was added with 2 
ml of 4% Ammonium Oxalate 
solution 
Presence of 
cloudy appearance 
Presence of 
calcium 
VII. Test of reducing sugar : 
5 ml of Benedict's qualitative 
solution was taken in a test tube and 
allowed to boil for 2 minutes and 
added 8 to 10 drops of the extract 
and again boiled for 2 minutes. The 
colour changes were noted. 
Dark green colour 
developed 
Presence of 
reducing sugar 
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VIII. 
a) 
2 ml of extract was treated with 2 ml 
of Picric acid 
Yellow colour 
developed. 
Presence of  
Alkaloid 
b) 2 ml of the extract was treated with 2 
ml of Phosphotungstic acid 
White Precipitate 
developed. 
Presence of 
Alkaloid 
IX. Test for Tannic acid : 
2 ml of the extract was treated with 2 
ml of Ferric chloride solution. 
Black precipitate 
was obtained 
Presence of 
Tannic acid 
X. Test for unsaturated compound : 
To 2 ml of  the extract 2 ml of 
Potassium permanganate solution 
was added. 
KMnO4  was 
decolourised 
Presence of un 
saturated 
compound 
XI. Test for Aminoacid : 
2 drops of the extract was placed on 
a filter paper and dried well. After 
drying 1% Ninhydrine is sprayed 
over the same and dried well. 
Violet colour 
develops 
Presence of 
Amino acid. 
XII. Test for Albumin : 
2 ml of the extract was added with 2 
ml of  Esboch's reagent. 
Yellow colour 
Precipitate 
formed. 
presence of 
Albumin. 
XIII. Test for type of compound : 
2 ml of the extract is added with 2 ml 
of  Ferric chloride solution. 
Green colour 
developed  
Oxyquinole 
epinephrine and 
pyrocatechol 
 
 The results are shown in observation and results. 
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ANTI-MICROBIAL STUDY 
Preparation of Extract : 
 To 5 gms of Pachai Karpoorathi Chooranam 50 ml. of water was added 
and kept in a boiling water bath for 20 minutes and then filtered. 
 The extract of the drug was tested with the following micro organism. 
1. Staphylococcus aureus. 
2. Escherichia coli 
3. Klebsiella 
4. Proteus 
5. Pseudomonas 
6. Candida albicans. 
Procedure : 
 The tube dilution method was used as a homogenous dispersion of the 
drug was more effective to test the antimicrobial activity of the drug.  Dilution 
method was used in the preliminary screening of the antimicrobial activity. 
 To the 5 ml of Nutrient Broth culture 0.5 ml. of the extract was added and 
the tubes were incubated at 37oC overnight.  The next day the tubes were 
examined for turbidity and subcultures were made on Nutrient Agar plates.  
Control tubes without drug were also included.  The plates were incubated 
overnight at 37oC and the next day the reading was taken. 
 The results are shown in observation and results. 
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PHARAMCOLOGICAL STUDIES 
 
Acute Toxicity Study of Pachai Karpoorathi Choornam 
Vehicle used: 
 Ghee was used as vehicle. Starting dose was 5mg/kg. And the subsequent 
doses are 10, 50, 100, 250, 500, 1000, 2000 and 4000mg/kg p.o. used in this 
study. 
Acute Toxicity Study 
 Pachai karpoorathi choornam suspended in Ghee was administered to the 
groups of wistar rats in a single oral dose by gavage using a feeding needle. The 
control group received an equal volume of the Ghee vehicle. Six females and 
males were used for each dosage level. The principles of laboratory animal care 
were followed. Observations were made and recorded systematically 1, 2, 4 and 
24 h after substance administration. The visual observations included skin 
changes, mobility, aggressiveness, sensitivity to sound and pain, as well as 
respiratory movements. They were deprived of food, but not water 16–18 h prior 
to the administration of the test suspension. Finally, the number of survivors was 
noted after 24 h and these animals were then maintained for a further 13 days 
and observations made daily. At the conclusion of the experiment, all surviving 
animals were sacrificed with anesthetic ether and their organs such as liver, 
lungs, heart, spleen, adrenals, kidneys, testes and ovaries were excised and 
weighed. The pathological observations of these tissues were performed on 
gross. The toxicological effect was assessed on the basis of mortality, which was 
expressed as LD50.  
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Evaluation of the Antiulcer Activity of Pachai Karpoorathi Chooranam, In 
Experimentally Induced Acute And Chronic Ulcers 
Materials and Methods 
 Albino rats of either sex weighing between 150-250 g were used for 
gastric ulcer models. They were fed with standard chow diet and were divided 
into groups of eight each. The distribution of animals in the groups, the sequence 
of trials and the treatment allotted to each group were randomised. Coprophagy 
was prevented by fasting the animals in cages with grating on the floor. Pachai 
Karpoorathi Chooranam and cimetidine were suspended in 1% solution of 
carboxy methyl cellulose (CMC) and administered orally in the dose of 200 
µg/kg and 50 mg/kg respectively in each experimental model. The suspensions 
of drugs were freshly prepared before administration. Gastric contents were 
assayed for total acidity by titration against 0.01 N NaOH to pH 8.0 using 
phenolphthalein as an indicator. The amount of HCl was calculated and 
expressed as mEq/L. The volume of the gastric content was measured and the 
total acid output was estimated. Pepsin activity of the gastric juice was 
determined and expressed in terms of µg/ml of tyrosin liberated per 4 h of 
gastric juice. Other bio-chemical parameters measured included total 
carbohydrates (TC) i.e. sum of total hexoses, hexosamine, and sialic acid’. The 
protein content (PR) of the gastric juice was also measured. Finally, the total 
carbohydrates to protein (TC/ PR) ratio i.e. the mucin activity, was determined. 
Only pylorus ligation was performed on one parallel group of animals (control 
PL), which received only 1% CMC solution. The same parameters were checked 
in this group so as to differentiate the additional effects of aspirin upon the 
pylorus-ligated group.  
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Experimental acute gastric ulcers: 
1. Aspirin plus pylorus ligation model:  
 Aspirin was suspended in 1% CMC solution and administered orally in 
the dose of 200 mg/kg in non-fasted rats once daily for 5 days. Pachai 
Karpoorathi Chooranam and cimetidine were administered orally to the 
respective treatment groups 30 min before each aspirin treatment whereas the 
control group received only vehicle (1% CMC solution). On the sixth day, 
immediately after aspirin treatment, pylorus-ligation was performed under 
ether anaesthesia on 36 h fasted rats. Four hours after pylorus-ligation, the 
animals were sacrificed by giving overdosage of ether. The stomachs were 
removed and opened along the greater curvature and the gastric lesions were 
observed using a 6.4 binocular magnifier. The gastric contents were 
collected, measured, centrifuged and subjected to biochemical analysis. The 
gastric ulcers were measured and the ulcer index was determined. 
2. Ethanol-induced gastric ulcer model:  
 1 ml of 80% ethanol was administered p.o. to 36 h fasted rats. In the 
treatment groups, Pachai Karpoorathi Chooranam and cimetidine were 
administered one hour before the administration of ethanol and the control 
group received 1% CMC solution. Two hours after ethanol administration, 
animals were sacrificed by giving overdosage of ether, and the ulcer index of 
the gastric mucosa was determined as mentioned above. 
Experimental chronic gastric ulcers: 
Acetic acid-induced gastric ulcer model:  
 Rats were starved for 24 h prior to an experiment and were divided into 
three groups, one for control and the other two for 10 days of chronic treatment 
with Pachai Karpoorathi Chooranam and cimetidine. Under light ether 
anaesthesia, a mid-line epigastric incision (0.75 to 1 .O cm) long was made and 
the stomach was exposed. 0.05 ml of 100% acetic acid was applied topically 
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using a cylindrical mould (7.5 mm diameter) which was allowed to remain there 
for 60 seconds. The acid solution was then removed by rinsing with 0.9% saline 
to prevent possible damage to the surrounding tissues close to the point of acid 
application. The abdomen was closed and from the second day after the 
operation, Pachai Karpoorathi Chooranam and. cimetidine were given once daily 
to the respective treatment groups for 10 days while the control group received 
only the vehicle. Rats were sacrificed on the 10th day, stomachs were removed, 
and the ulcer index as well as the score for intensity of the gastric lesions was 
measured where score 0 = no ulcer, 1 = superficial mucosal erosion, 2 = deep 
ulcer or transdermal necrosis, and 3 = perforated or penetrated ulcer. 
Ulcer index = 1 O/X where, 
              Total area of stomach mucosa   
X=. ----------------------------------------------- 
                   Total ulcerated area 
 The results are showed in observation and results. 
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CLINICAL ASSESSMENT 
 
 The drug PACHAI KARPOORATHI CHOORANAM has chosen as a 
therapeutic agent for GUNMAM. 
About the Disease : 
F‹k«53 
ntWbga®fŸ : 
 Fšk«, tÆ‰WŸòusš, tÆ‰WŸ òusYl‹ nehjš. 
ïaš : 
 brÇahik, tÆ‰¿š vÇ¢rš, thªâ, clšt‹ik Fiwjš, 
njf«bkÈjš, kd« F‹wš M»a Fz§fisíila nehah«. nkY« 
tÆ‰WŸ czî brÇ¡fhkš fh‰W To tÈíl‹ gªJ nghš òus¢ 
brŒí« nehŒ vdî«, ïªnehahš tUªJ« nghJ kd« F‹W« 
fhuz¤jhY«, tÈ tU« nghJ nehÆdid K‹g¡f« F‹w it¡F« 
fhuz¤jhY« ïjid F‹knehŒ v‹g®. 
nehŒtU« tÊ : 
According to the siddhars, Agasthiyar and Yugi the aetiology of Gunmam are, 
 ''V»a F‹kªjhD« 
 vGªnjh® Éj§fŸ brhšnth« 
 th»a ã¤j¤njhL 
 thjK« ãÇªJ nrÇš 
 th»a thŒÚ® nrU« 
 thªâahF« ghnu35'' 
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 "brŒahd F‹k¤âD‰ g¤â j‹id¢ 
  br¥ãlnt Jt®¥ghd bghá¥ãdhY« 
 ikahd k§ifíl‹ kh®¡f¤ jhY« 
  tifahF§ »H§Ftif aUªjyhY« 
 cŒahd ÄsFfh íiu¥ã dhY« 
  cWgáia al¡»oD kªj¤ jhY« 
 ijahs r©lhs nfhg¤ jhY« 
  rÈ¥ghY§ F‹k« tªJ jh¡F« ghnu54" 
In our system, It is mainly caused by 
i. Dietic variations 
ii. Karmic Low 
iii. Excessive consumption of astringent food. 
iv. Excessive indulgence in sexual intercourses. 
v. Excessive intake of roots and spices. 
vi. Unhealthy food habits - especially not adhering to a proper time schedule. 
vii. Emotional imbalance - anger, fear, anxiety etc. 
"F‹k« tªJ fhuzªjh ndnjh btÅš 
 FobfL¤J tÆbwÇ¢rš bfh©l ght« 
e‹ikÆšyh kd¡ftL bgU¤j ght« 
 ešnyhiu kd«nehf¥ gÊ¤j ght« 
j‹ikÆšyh ãw®gá¡f î©lghtŠ 
 r©lhs j¤Jtnk brŒj ght« 
ï«ikÆny ï¥ght« tªJ R‰¿ 
 ajdhny F‹kbkd btL¤j thnw"19 
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 The line portrays than Gunmam as the cumulative effect of sins 
committed by an individual like, 
1. Spoiling the harmony of a family 
2. Despicable thoughts, words and action. 
3. Talking ill of others especially nobel men and  
4. Not sharing the food with poor and needy. 
 These ill-attitudes of the people can cause perpetual tension to them and 
to their neighbours. 
 The perpetual tension and agony impact a malfunctioning of the body 
especially the stomach and the ultimate result in gastric disorders. 
F¿Fz§fŸ18 : 
• tÆWòu£o nehjš 
• czÉš btW¥ò 
• gáÆ‹ik 
• Fk£lš, thŒ Ú® Cwš 
• vâbuL¤jš 
• òËna¥g«  
Selection of the Patients : 
 In our Siddha system of medicine, so many single and compound 
medicines are available for Gunmam. 
 The clinical study was carried out in O.P.of Arignar Anna Government 
Hospital, Chennai - 106. 
 40 cases from both sex of various age group were selected and treated as 
out patient department.  They were clinically diagnosed on the basis of siddha 
principles with modern laboratory findings. 
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 The routine investigation of blood, urine, motion, blood sugar, urea, 
serum cholesterol and endoscopy have been studied. 
Including Creteria : 
• Age  20 - 60 years, sex, occupation, personal habits and diets, socio - 
economic status. 
• Epigastric pain. 
• Heart burn. 
• Regurgitation. 
• Nausea 
• Vomiting 
• Loss of appetite 
• Distension of abdomen 
Excluding Creteria : 
• Complication of peptic ulcer such as 
 - Haemorrhage 
 -  Perforation 
 -  Gastric outlet obstruction. 
• Radiating abdominal pain as in pancreatitis, appendicitis. 
• Acute abdominal colics 
• Cancer of the stomach. 
• Gall stone and Hiatus hernia 
• Cirrhosis of liver and Jaundice 
Drug and Dosage : 
 The patients were only administered Pachai Karpoorathi Chooranum as a 
dose of 2.1 gram three times daily, before food with ghee. 
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Diet and Medical Advise14 
 It has been told by Hippocrates, the father of medicines long since that, 
"Your food shall be your medicine" 
Do's 
 Following foods to be taken more, 
1. Timely food 
2. Banana 
3. Almond milk 
4. Raw goat's milk 
5. Carrots and cabbage juice 
6. Butter milk 
7. He should chew every morsel throughly 
8. Meals must be small and frequent 
Don'ts 
1. Intake of food stuff during stress and anxiety. 
2. Foods and drinks which are too hot or too cold can be avoided. 
3. Spicy foods, carbonated drinks. 
4. Smoking and consumption of alcohol. 
5. Intake of steroids and NSAIDS 
Line of Treament : 
 All the selected patients were undergone for the diagnosis of Gunmam by 
the symptoms like Epigastric pain, Heart burn, Regurgitation, Nausea, vomiting, 
Distension of abdomen and investigation like endoscopy, blood and urine 
routine. 
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 Then the test drug was administered to the patients for 9 weeks.  The 
clinical signs and symptoms like Epigastric pain, Heart burn, Regurgitation and 
Distension of abdomen were observed regularly under the supervision of HOD, 
Lecturers and Asst. Lecturers. 
BIO-STATISTICAL STUDY 
 Bio-statistical study was carried out 40 out-patients in Post-graduate's 
Department of Gunapadam, Govt. Siddha Medical College attached to Arignar 
Anna Hospital of Indian Medicine, Chennai - 106. 
CRETERIA FOR SELECTION OF BIO-STATISTICS 
 Analysis of Subjective parameters : (Before and After Treatment)  
• Epigastric pain 
• Heart Burn 
• Abdominal distension 
 The results of Bio-statistical analysis of subjective parameters are 
explained at Results and Observation (Table - 8). 
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OBSERVATION AND RESULTS 
 The test drug Pachai Karpoorathi Chooranam was analysed under the 
following studies Bio-Chemical analysis, Anti-microbial study, Pharmacological 
study, Bio-statistical study and Clinical study. 
Bio-Chemical Analysis : 
 Done at Government Siddha Medical College, Chennai - 106. 
 Extract of pachai Karpoorathi Chooranam shows the presence of, 
Acid Radicals : 
 Sulphate, Chloride, Oxalate and Phosphate. 
Basic Radicals : 
 Calcium, Zinc, Copper, Iron. 
Miscellaneous : 
 Reducing sugar, Alkaloid, tannic acid, unsaturated compound, Amino 
acid, albumin, Oxyquinole, epinephrine and pyrocatechol. 
Phsico-Chemical Standards of Pachai Karpoorathi Chooranam : 
Loss on drying @ 105oC  5.16% 
Ash Value 2.59% 
Water solublity 44.68% 
Acid insoluble ash 0.55% 
Alkalinity as CaCO3 in water soluble ash 0.10% 
pH at 10% aqueous solution 5.15 
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Inorganic Analysis - Quantitative : 
Copper as Cu 12 mg / kg 
Zinc as Zn 27 mg / kg 
Iron as Fe 675 mg / kg. 
 
ANTI-MICROBIAL STUDY : 
 Done at Vel's College of Pharmacy, Pallavaram, Chennai. 
 Extract of Pachai Karpoorathi Chooranam shows, 
• Staphylococcus aureus, candida albicans, proteus - Not sensitive. 
• Escheritia coli and klebsiella - Highly sensitive. 
• Pseudomonas - Moderatively sensitive. 
PHARMACOLOGICAL STUDY  
 The acute toxic study and antiulcer activity of Pachai Karpoorathi 
Chooranam were done at Vel's College of Pharmacy, Pallavaram, Chennai. 
Acute Toxicity-Results 
 Death was recorded during the treatment period in treated groups given 
4g/kg of Pachai karpoorathi choornam orally. The animals showed changes in 
general behavior and other physiological activities like giddiness, sniffing, 
aggressiveness, tachypnoea, convulsion finally at the dose level of 4g/kg.. There 
were no significant differences between the control and treated groups in the 
body and organ weights of rats.  There is a significant difference in the organs 
like lung, liver (**P<0.01) and heamatological parameters like Hb (*P<0.05) and 
W.B.C. (**P<0.01) were observed. Similarly there was a remarkable alterations in 
biochemical parameters like Glucose, Sodium, AST and ALP (**P<0.01). 
Pathological examinations of the tissues on a gross and macroscopic basis 
indicated that there were no detectable abnormalities. Hence, it can be concluded 
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that a test substance is practically toxic or lethal after an acute exposure at the 
dose range of 4g/kg. This test limit for acute oral toxicity is generally considered 
to be 4.0 g/kg body weight.  
RESULTS OF ANTIULCER STUDY 
Aspirin plus pylorus-ligation model : 
 In this model, the parameters investigated were the ulcer index, the 
volume of gastric content, total acidity, total acid output, pepsin activity, total 
carbohydrates (TC), protein content (PR) and the TC/PR ratio. Same parameters 
were also checked in the control PL group. Aspirin plus pylorus-ligated 
(aspirin+PL) group showed significant increase in the ulcer index and acid 
secretory parameters like the volume of gastric content, total acidity and total 
acid output (Table 4), and decrease in mucin activity of gastric mucosa (Table 5) 
when compared with those of control PL group of animals. Administration of 
Pachai Karpoorathi Chooranam resulted in significant reduction in the ulcer 
index (0.25+0.05) when compared with its control (aspirin+PL) group (Table 4). 
Though, the volume of the gastric content increased significantly, the rise in the 
total acid output was insignificant as total acidity decreased significantly when 
compared with the control group. In the cimetidine-treated group, the ulcer 
index, the volume of the gastric content, total acidity, the total acid output and 
the pepsin activity were reduced as compared to the control group (Table 4). 
Pachai Karpoorathi Chooranam was also studied for its effect on the dissolved 
mucus content of the gastric juice. It showed insignificant rise in hexosamine 
and fructose with fall in total hexoses (P <0.05) and sialic acid (Table 5) when 
compared with the control group. Hence, the total carbohydrate content (TC) 
was found to be reduced by Pachai Karpoorathi Chooranam pretreatment 
whereas all the four individual carbohydrate contents were found to increase 
significantly by cimetidine pretreatment and thereby there was a significant rise 
in TC in this group (Table 5). Simultaneously, there was a fall in the protein 
content (PR) of the gastric juice in both Pachai Karpoorathi Chooranam as well 
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as cimetidine treated groups. However, the fall was found to be statistically 
significant in the later group (Table 5). As a result, TC/PR ratio was found to be 
increased significantly in the cimetidine treated group whereas the rise was 
insignificant in the Pachai Karpoorathi Chooranam treated group when com-
pared with that of the control group (Table 5). 
Ethanol-induced gastric ulcer model:  
 Ethanol produced haemorrhagic gastric lesions in the glandular portion of 
the stomach mucosa. Pachai Karpoorathi Chooranam reduced these lesions as 
was evident from the significant reduction in the ulcer index when compared 
with the control group. Cimetidine also significantly reduced the ulcer index of 
ethanol induced ulcers (Table 6). 
Acetic acid-induced gastric ulcer model:  
 The topical administration of acetic acid produced penetrating lesions in 
the pyloric portion of the gastric mucosa at the site of application. Pretreatment 
with Pachai Karpoorathi Chooranam for 10 days resulted in a significant 
reduction of the ulcer index, score for intensity, and total lesion area (Table 7). 
Mortality of animals was prevented in presence of Pachai Karpoorathi 
Chooranam against acetic acid-induced gastric ulceration. Cimetidine did show a 
significant protective effect against chronic gastric ulcers (Table 7).  
DISCUSSION 
 In the present study, Pachai Karpoorathi Chooranam has been shown to 
possess antiulcer activity against experimentally induced acute and chronic 
gastric ulcer models. It has shown a significant reduction in the gastric lesions of 
the aspirin treated pylorus ligated group of animals. Its antiulcer activity in this 
model is evident from its significant reduction in acid secretory parameters viz. 
total acidity and pepsin activity. The stomach digestive effect of accumulated 
gastric juice in the induction of gastric ulcers is well documented in the pylorus 
ligation model. Increased gastric secretion is also implicated in the causation of 
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gastric ulcer by anti-inflammatory agents. Pachai Karpoorathi Chooranam has 
also been studied in this model for its effect on soluble  mucosubstances as 
increased. It is thought to be initiated by back diffusion of HCI into the mucosa. 
It has been reported that back diffusion of HCI and increased capillary 
permeability induced by acetic acid. Hence, it can be suggested from our study 
that Pachai Karpoorathi Chooranam possesses antiulcer activity against 
experimentally induced acute and chronic gastric ulcer models. The mechanism 
of its action can be attributed to its antisecretory action and cytoprotective 
property.  
Table 4 Effect of PKC on total and free acidity, gastric volume and ulcer 
index  
Groups  Total acidity 
(mEq/l) 
Free aciditly 
(mEq/l) 
Gastric 
Volume 
(ml/100g)  
Ulcer index 
Normal 
 
159±1.46ns 116.33±0.55 2.55±0.07 1.11±0.03 
CMC control  
 
160±1.39ns 118.83±0.94 2.5±0.05 1.21±0.04 
Control (Aspirin + ligation) 
 
252±2.54 182.33±0.66 4.97±0.04 4.37±0.04 
Ranitidine (50mg/kg) 
 
178±2.37** 132.16±0.94** 3.03±0.03** 1.44±0.03** 
PKC (400mg/kg) 
 
207±5.16** 146.16±0.7** 3.54±0.01** 2.11±0.07** 
PKC (800mg/kg) 
 
197±2.31** 140.32±0.66** 3.23±0.02** 1.87±0.04** 
*P values <0.05 as compared to Aspirin + ligation control 
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Figure 5 : 
ANTI-ULCER STUDY ON ALBINO RATS 
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Table 5 - Effect of PKC on mucin activity of gastric juice in aspirin +pylorus ligation induced ulcers  
*P values: <0.01 as compared to aspirin + ligation control TC-Total carbohydrate, P- Protein. All values represent Mean±SEM; n=6 in 
each group.  
Groups  Protein (mg/ml)** Hexose  
(mg/ml)** 
Hexosamine 
(mg/ml)** 
Fructose 
(mg/ml)** 
TC (mg/ml)** TC:P** 
Control 252.5±2.56 
 
1082±29.49 428.83±6.26 93.66±1.52 1636.83±21.13 6.06±0.08 
SCMC control .251±5.68 
 
1064±27.62 423±4.91 63.16±0.83 1667.66±17.82 6.06±0.11 
Aspirin+ligation 
control 
 
440.66±5.14 617.66±4.96 190.83±4.81 85.5±1.33 905.66±13.86 1.9±0.05 
Ranitidine (50mg/kg) 305.5±4.25 972.5±5.41 347.33±5.58 102±0.73 1535.83±37.27 4.71±0.07 
 
PKC (400mg/kg) 
 
340.83±3.62 783±3.42 263.16±7.23 94±0.73 1232.83±15.46 3.55±0.04 
 
PKC (800mg/kg) 
 
312.16±4.34 809±5.12 286.83±3.97 97.66±0.42 1317.66±22.06 4.13±0.04 
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Table 6. Effect of Pachai Karpoorathi Chooranam on ethanol-induced gastric ulcer. 
 
Treatment Dose Ulcer index 
Control ------------- 0.87 ± 0.07 
P.K.C.  400 mg/kg 0.30 ± 0.02* 
P.K.C. 800 mg/kg 0.19 ± 0.01* 
Cimetidine 50 mg/kg 0.18 ±0.01* 
‘P <0.01 when compared with control group. 
All values represent mean±SEM; n = 6 in each group. 
 
Table 7. Effect of Pachai Karpoorathi Chooranam on acetic acid-induced chronic gastric ulcer for 10 days. 
Treatment Dose Ulcer incidence Ulcer index Total lesion area 
(mm*) 
Score for  
intensity 
 Mortality 
No. % 
No.  
 
. %  
 
Control -------- 6/6 100 
 
0.87±0.07 41.25±3.54 2.71±0.16 3/6 50 
P.K.C.  400mg/kg 6/6 100 
 
0.30±0.02* 8.12±0.78 0.1±0.03 2/6 33 
P.K.C. 800mg/kg 6/6 100 
 
0.24±0.01* 7.34±0.66** 0.06±0.05 0/6 0.00 
Cimetidine 50mg/kg 6/6 100 
 
0.20±0.01** 5.11±0.58 0.09±0.03 0/6 0.00 
*P <0.05; **P <0.001 when compared with control group. All values represent mean±SEM; n = 6 in each group. 
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CLINICAL OBSERVATIONS 
  
 The test drug Pachai Karpoorathi Chooranam was given daily to the 
patients and they were examined clinically. Reduction of epigastric pain, heart 
burn and abdominal distension were taken as important signs of progress.  The 
duration of treatment ranged between 48 to 63 days according to the severity of 
signs and symptoms of the patient.  The clinical investigations were done 
before and after treatment. 
 The observation regarding, 
• Age variation 
• Sex Difference 
• Personal Habits 
• Signs and Symptoms during admission 
• Results 
• Improvement showing signs and symptoms after treatment 
are recorded and tabulated as follows . 
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CLINICAL STUDY ON PACHAI KARPOORATHI CHOORANAM IN OUT-PATIENT DEPT. IN THE MANAGEMENT OF GUNMAM 
S.  
No 
O.P. 
No. 
Name, 
Age / Sex 
Complaints 
Duration of 
Treatment 
in days 
BT & 
AT 
BLOOD URINE MOTION 
X Ray BMS / 
Endoscopy Result TC Cells 
/ Cumm 
DC (%) ESR (mm) Hb  
g % 
Sug 
mg% 
Ur 
mg% 
Cho 
mg% Alb Sug Dep Ova Cyst P % L % E % 1/2 Hr. 1 Hr. 
1 5472 Rukkumani 
45/F 
Epigastric pain, heart burn, regurgitation, 
abdominal distension 56 
BT 8400 57 40 3 14 25 12 87 25 182 N N FEP N N  
Good 
AT 9100 60 37 3 12 20 12 90 22 178 N N N N N  
2 8468 Basha 
35/M 
Epigastric pain, heart burn 63 
BT 9000 58 36 6 10 20 10.5    N N OPC N N  
Good 
AT 9400 61 29 10 12 24 11 136 22 184 N N OPC N N  
3 9747 Purushothaman 
41/M 
Epigastric pain, heart burn,regugitation, 
nausea, abdoninal distension 63 
BT 10800 62 33 5 20 38 11 255 22 181 N N OPC N N  
Good 
AT 9600 65 31 4 10 19 11.5 230 3 197 N N OPC N N  
4 1162 Adhimoolam 
40/M 
Epigastric pain, heart burn, regurgitation, 
abdominal distension 63 
BT 10900 67 29 4 8 20 11 130 28 208 N N N N N  
Good 
AT 10300 63 35 2 5 12 11 112 24 202 N N N N N  
5 9980 Mannar 
60/M 
Epigastric pain, heart burn, regurgitation, 
abdominal distension. 56 
BT 10600 61 34 5 15 34 11 148 23 179 N N FPC N N  
Good 
AT 10200 57 38 5 12 20 11 135 28 194 N N FPC N N  
6 2292 Moorthi 
68/M 
Epigastric pain, heart burn, abdominal 
distension, constipation 56 
BT 10500 63 31 6 12 25 11 92 22 211 N N OPC N N  
Moderate 
AT 9200 67 30 3 15 26 11.5 94 21 204 N N OPC N N  
7 5078 
Kanagaraj 
37/M 
Epigastric pain, regurgitation, nausea, 
abdoninal distension. 56 
BT 9700 56 40 4 7 14 14 112 14 186 N N N N N  
Moderate 
AT 8900 59 37 4 5 15 14 121 13 185 N N N N N  
8 5317 
Pushpam 
57/F 
Epigastric pain, heart burn, regurgitation, 
abdominal distension 63 
BT 10900 60 34 6 24 40 10 266 30 207 N N OPC N N  
Good 
AT 10200 58 36 6 20 37 10 236 27 202 N N OPC N N  
9 6021 
Sukira velu 
67/M 
Epigastric pain, heart burn, nausea 56 
BT 9400 62 31 3 5 12 14.2 113 13 234 N N N N N AG & BD 
Good 
AT 8700 56 42 2 4 8 15 110 14 227 N N N N N N 
10 6382 
Gnanasekaran 
46/M 
Epigastric pain, heart burn, abdominal 
distension 56 
BT 10200 60 34 6 2 3 11 113 20 189 N N N N N  
Moderate 
AT 9600 56 40 4 4 9 12 110 24 196 N N N N N  
11 7256 
Sankar 
43/M 
Epigastric pain, heart burn regurgitation, 
neusea, abdominal distension 63 
BT 10600 63 31 6 10 18 12 133 311 184 N N N N N  
Good 
AT 10400 60 37 3 10 14 12.5 135 24 197 N N N N N  
12 7583 
Periasami 
50/M 
Epigastric pain, regurgitation, nausea, 
vomiting, abdominal distension 63 
BT 9900 60 34 6 11 26 9.5 260 28 189 N N N N N  
Good 
AT 10200 56 42 2 12 23 10 223 27 204 N N N N N  
13 7890 
Vaidegi 
32/F 
Epigastric pain, heart burn 56 
BT 8500 70 24 6 8 15 8 98 26 201 N N N N N  
Moderate 
AT 8700 64 37 3 5 10 8 102 23 210 N N N N N  
14 9568 
Selvi 
37/F 
Epigastric pain, heart burn, nausea. 56 
BT 9700 55 40 5 24 35 9.5 110 32 178 N N FPC N N  
Good 
AT 10100 60 38 2 20 30 9.5 98 23 187 N N FEC N N  
S.  O.P. Name, Complaints Duration of BT & BLOOD URINE MOTION X Ray BMS / Result 
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No No. Age / Sex Treatment 
in days 
AT TC Cells 
/ Cumm 
DC (%) ESR (mm) Hb  
g % 
Sug 
mg% 
Ur 
mg% 
Cho 
mg% Alb Sug Dep Ova Cyst 
Endoscopy 
P % L % E % 1/2 Hr. 1 Hr. 
15 494 
Valli 
40/F 
Epigastric pain, heart burn, abdominal 
distension 63 
BT 9500 59 36 5 12 20 10.5 80 18 175 N N N N N  
Good 
AT 10200 60 37 3 10 22 11 93 22 187 N N N N N  
16 94 
Pooranam 
45/F 
Epigastric pain, heart burn, nausea, 
abdominal distension 63 
BT 10800 66 30 4 25 54 11 104 21 208 N N OPC N N  
Good 
AT 10300 65 29 6 18 38 12 97 24 210 N N OPC N N  
17 1101 Selvam 
39 / M 
Epigastric pain, heart burn, regurgitation, 
nausea, abdominal distension, loss of 
appetite, constipation 
56 
BT 10600 63 32 5 2 3 12 93 20 183 N N FPC N N AG 
Moderate 
AT 10800 65 29 6 3 5 11 97 24 169 N N N N N N 
18 4795 Arumugam 
32/M 
Epigastric pain, heart burn regugitation, 
nausea, vomiting 56 
BT 7800 70 28 2 6 13 13 127 31 205 N N N N N  
Good 
AT 9100 64 34 2 8 17 13 115 24 210 N N N N N  
19 7644 Venkatesan 
29/M 
Epigastric pain, heart burn 56 
BT 10300 52 45 3 9 15 2.5 90 20 197 N N N N N  
Good 
AT 11000 54 44 2 10 17 13 97 23 210 N N N N N  
20 7839 Annamalai 
65/M 
Epigastric pain, heart burn 56 
BT 9800 57 36 7 4 11 10 109 31 189 N N N N N  
Good 
AT 9200 59 36 5 5 10 11 100 27 180 N N N N N  
21 
 
1641 Kamalam 
60/M 
Epigastric pain, heart burn, abdominal 
distension 56 
BT 9100 57 38 5 82 100 9 83 21 179 N N N N N  
Good 
AT 9800 55 40 5 47 85 10 92 24 182 N N N N N  
22 1732 Vasantha 
64/F 
Epigastric pain, heart burn,  regurgitation, 
nausea, abdominal distension 56 
BT 9800 60 33 7 12 20 10 93 25 197 N N FEC N N  
Good 
AT 10200 65 30 5 10 17 9 94 26 180 N N FEC N N  
23 3782 Ramanan 
41/M 
Epigastric pain, heart burn, regurgitation, 
oral ulcer 48 
BT 9000 52 44 4 15 26 12 101 24 190 N N N N N  
Moderate 
AT 9400 56 39 5 10 24 12 107 22 186 N N N N N  
24 9071 Valli ammai 
62/F 
Epigastric pain, heart burn, regurgitation, 
nausea, abdominal distension 56 
BT 10000 62 32 6 20 44 10 95 25 196 N N N N N  
Good 
AT 9600 60 37 3 20 40 10 101 24 182 N N N N N  
25 3096 Rengammal 
40/F 
Heart burn, oral ulcer, abdominal 
distension 48 
BT 9400 57 38 5 4 12 10 89 22 177 N N N N N  
Good 
AT 9600 58 38 4 5 10 10 92 24 184 N N N N N  
26 5806 Kumar 
23/M 
Epigstric pain, heart burn, loss of appetite, 
constipation 48 
BT 9200 63 30 7 3 7 12 93 27 160 N N N N N  
Good 
AT 9700 65 28 7 4 8 12 98 30 177 N N N N N  
27 5994 Tharani 
30/F 
Epigastric pain, heart burn, regurgitation, 
nausea, abdominal distension 56 
BT 9800 57 38 5 24 40 10 115 18 169 N N OPC N N  
Mild 
AT 10100 58 38 4 20 35 12 104 20 174 N N N N N  
28 2621 Usha Devi 
25/F 
Epigastric pain, regurgitation, abdominal 
distension 56 
BT 9800 60 34 6 12 20 11 85 24 153 N N OEC N N  
Good 
AT 10100 63 35 2 17 30 10 94 26 169 N N OPC N N  
 
S.  O.P. Name, Complaints Duration of BT & BLOOD URINE MOTION X Ray BMS / Result 
124 
 
No No. Age / Sex Treatment 
in days 
AT TC Cells 
/ Cumm 
DC (%) ESR (mm) Hb  
g % 
Sug 
mg% 
Ur 
mg% 
Cho 
mg% Alb Sug Dep Ova Cyst 
Endoscopy 
P % L % E % 1/2 Hr. 1 Hr. 
29 4856 
Ramasami 
28/M 
Epigastric pain, heart burn, nausea 56 
BT 9400 52 44 4 10 16 11 84 18 150 N N OPC N N  
Moderate 
AT 9800 60 37 3 8 15 11 89 24 166 N N N N N  
30 4899 
Selvaraj 
44/M 
Epigastric pain, heart burn, regurgitation, 
abdominal distension 48 
BT 10200 62 27 11 12 20 12 108 26 192 N N FPC N N  
Good 
AT 10600 61 33 6 4 8 12 96 27 185 N N FPC N N  
31 7487 
Prabu 
22/M 
Epigastric pain, heart burn, constipation 48 
BT 8800 65 32 3 10 15 13 104 30 197 N N FEC N N  
Good 
AT 8900 65 32 3 12 19 13 116 30 186 N N FEC N N  
32 7590 
Malliga 
57/F 
Epigastric pain, heart burn, regurgitation, 
loss of appetite, abdominal distension 48 
BT 9200 63 31 6 12 25 10.5 83 23 195 N N OPC N N  
Good 
AT 9400 60 36 4 10 15 11 97 26 187 N N N N N  
33 8599 
Ameer boy 
40/M 
Epigastric pain, heart burn regurgitation, 
abdominal distension 56 
BT 9900 60 34 6 10 18 12 137 31 215 N N N N N BD 
Good 
AT 9700 56 42 2 14 21 12 118 27 203 N N N N N N 
34 8622 
Jeya 
26/F 
Epigastric pain, heart burn, abdominal 
distension 48 
BT 10500 58 37 5 6 14 12 99 28 210 N N N N N  
Good 
AT 9500 60 36 4 12 30 13 105 27 195 N N FEC N N  
35 9406 
Jai Shanthi 
35/F 
Epigastric pain, heart burn regurgitation, 
nausea, abdominal distension 56 
BT 8600 71 27 2 2 4 9 87 24 185 N N FEC N N  
Good 
AT 9100 66 30 4 3 5 9 88 26 191 N N FEC N N  
36 9481 
Sheela 
20/F 
Epigastric pain, heart burn, regurgitation, 
nausea 48 
BT 10000 63 31 6 12 20 10 99 15 143 N N OEC N N  
Mild 
AT 9700 57 37 6 13 24 11 104 17 152 N N N N N  
37 9642 
Samundeeswari 
23/F 
Epigastric pain, heart burn, abdominal 
distension 48 
BT 9800 54 38 8 12 20 11 103 28 176 N N OEC N N  
Moderate 
AT 10500 55 39 6 10 14 11 109 24 197 N N N N N  
38 9726 
Uma 
30/F 
Epigastric pain,heart burn, loss of 
appetite, nausea, abdominal distension 48 
BT 10200 62 33 5 5 12 10 118 27 163 N N FEC N N  
Good 
AT 9800 60 37 3 2 3 10.7 104 19 172 N N FPC N N  
39 337 
Perumal 
62/M 
Epigastric pain, heart burn, regurgitation, 
abdominal distension. 48 
BT 9000 55 42 3 8 13 12 137 18 182 N N N N N  
Good 
AT 9600 58 40 2 5 13 13 139 18 184 N N N N N  
40 827 
Deepa 
35/F 
Epigastric pain, heart burn, regugitation, 
abdominal distension 48 
BT 10500 62 34 4 8 15 9 110 29 209 N N FPC N N  
Moderate 
AT 10300 61 36 3 9 17 9 104 30 212 N N FPC N N  
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Abbreviation : 
 
BT - Before Treatment, AT - After Treatment, TC - Total WBC Count, DC - Differential Count, Hb - Haemoglobin, Sug - Glucose, Ur - Urea,  
Cho - Cholesterol, Alb - Albumin, Dep - Deposit, OPC - Occasional Puss Cells, FPC - Few pus cells, N - Nil, P - Neutrophills, L - Lymphocyte, 
E - Easinophills, AG - Antrl Gastritis, BD - Bulbar duodenitis 
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BEFORE TREATMENT 
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AFTER TREATMENT 
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Result : 
 The results are based on the clinical improvement on signs and 
symptoms before and after treatment. 
• The total relief from symptoms were considered as good relief. 
• The relief from epigastric pain, heart burn, regurgitation were 
considered as moderate relief. 
• The relief from heart burn, nausea and vomiting were considered 
as mild relief. 
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Table - 8 :  Results of statistical analysis of subjective parameters observed 
before and after treatment of (n = 40) patients. 
S. 
No. 
Parameters Percentage present Statistical 
test 
criterion 
Probability 
Value (P) 
Statistical 
Significance 
of the 
Difference 
Before 
Treatment 
After 
Treatment 
Difference 
1 Epigastric pain 39/40 
(97.5) 
29/39 
(74.35) 
23.74 Z = 9.8 < 0.05 Significant 
2 Heart Burn 37/40 
(92.5) 
28/37 
(75.67) 
18.19 Z = 8.7 < 0.05 Significant 
3. Abdominal 
distension 
28/40 (70) 16/28 
(17.14) 
18.37 Z = 7.3 < 0.05 Significant 
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DISCUSSION 
 Todays fast moving life style with its unhealthy food habits and 
increased stress are taking its roll on human health.  Gunmam is one of them, 
increasing at an alarming rate. 
 As it has been told by Hakkem P. Mohamad Abudllah Saibu in 
ANUBOGA VAIDYA NAVANEETHAM (Part VIII) that Pachai Karoorathi 
Chooranam, an antiulcer medicine and also its ingredients Pachai Karpooram 
Cinnamon bark, black pepper are used to cure Acid peptic disorders.  Nut meg, 
cinnamon leaves, siru-nagappu and black pepper root are having carminative 
and stomachic actions.  This medicine can be known to act good on peptic 
ulcer disease more over the informations from literatures and web sites proved 
this evidence true. 
"bjhl® thj gªjÄyhJ F‹k« tuhJ"   (nju‹) 
 As per siddha system, Gunmam is caused by the derangement of vatha 
kutram. 
 Pachai Karpooram is having salt and bitter taste. 
"áWf msnthL ................ 
mKyf‰W« .............. gh¡F« 
............... brŒif eÉš"  (k.j.gh.) 
"bfhoWthŒ bjh©il ................ 
...................... c¥ghš tU«"64 
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 Quoted that a lot of salivation occurs in the mouth due to the taste salt.  
The production of saliva help better digestion of food. 
"Fl‰òG F£l« ................... 
.......................................................... 
ts®¡F« bkËjh« brÇ¡f¡ fufu¥...."64 
 From the above  poem, it is understood that bitter taste has vermicide 
action heals the ulcers caused by the worms and also improves the digestion. 
 As per the siddha text, Gunmam is caused by the derangement of vatha 
kutram, 
"thj« nkÈ£lhš kJu« òËí¥ò" (f©QrhÄa«) 
 It is proved that vatham is passified by salt taste. 
 Hence the drug Pachai Karpoorathi Chooranam which is salty in taste, 
reduce the deranged vatha kutram. 
 Bio-chemical analysis of pachai karpoorathi chooranam shows the 
presence of calcium, zinc, copper, Iron which have the antiulcer properties. 
 The anti-microbial study of Pachai karpoorathi Chooranam shows that it 
is highly sensitive E-coli and klebsiella and moderatively sensitive to 
pseudomonas. 
 The pharmacological study of pachai karpoorathi chooranam shows that 
it passifies the acidity levels of the gastric juice and protects the gastric mucosa 
from injury.  Hence it is proved to be good for Gunmam. 
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 The clinical study was conducted under the following creteria age, sex, 
soci-economic status, personal habits, diet and occupation. 
 40 patients of age from 20 to 60 were selected and pachai karpoorathi 
chooranam was given with ghee three times a day before food. 
"nkf« tÆ‰bw¿î É¡fyHš - khfhr§ 
F‹k« tw£á ...................."60 
 The above lyrics states that cow ghee has the anti ulcer activity. 
 Diagnosis was done on the basis of modern and siddha principles.  The 
routine investigations of blood, urine, stools and endoscopic studies were done.  
All patients were diagnosed as Gunmam. 
 Among 40 patients, the epigastric pain was found to be decreased in 
73% of patients. 
 The heart burn was found to be decreased in 76% of patients. 
 Abdominal discomfort was found to be decreased in 57% of patients. 
 My clinical findings showed that the people belonging to the age group 
of 20 to 40 years are mostly affected.  It is noted that people belonging to poor 
socio economic group, mostly of males who are drivers and labours are more 
prone to Gunmam.  People taking much of non-vegetarian food items and 
alcohol are also commonly affected. 
 On giving pachai karpoorathi chooranam, people belonging to the 
following category showed better improvement. 
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• Male, middle class and rich people 
• 20 to 40 years age group 
• Students and house wives 
 The alcoholics, non vegetarians and smokers showed late recovery. 
 Pachai karpoorathi chooranam acts good in 73%, moderate 23% and 
mild in 5%. 
 After the treatment the complete blood, urine, motion examinations 
were done and the results were normal as they found before. 
 No unwanted and adverse effects have been noted during the course of 
treatment. 
 From the above studies, it is found that Pachai Karpoorathi Chooranam 
has antiulcer property and effective in the treatment of Gunmam. 
 Hence, the Pachai Karpoorathi Chooranam has been proved to be 
clinically effective for Gunmam. 
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SUMMARY 
 The formulation of Pachai Karpoorathi Chooranam was selected for 
anti-ulcer activity with great inspiration since it was described in siddha 
literature as a effective drug for all types of Gunmam. 
 Gunapadam aspect of the drug gave so much hope about the ulcer 
healing activity of the drug. 
 Modern aspect showed the drug is beneficial in gastro-intestinal 
disorders. 
 The bio-chemical analysis expressed the presence of calcium, zinc, 
copper, Iron which are known well for their ulcer healing property. 
 The microbial analysis showed the drug was highly sensitive to E-coli 
and klebsiella. 
 The phamacological study of the drug showed significant antiulcer 
activity. 
 The clinical study also proved the pharmacological action of drug 
shows, 
• Good response in 73% of cases. 
• Moderate response in 23% of cases. 
• Mild response in 5% of case. 
 The above studies of the drug "Pachai Karpoorathi Chooranam" state 
that it can be successfully used for the treatment of Gunmam. 
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CONCLUSION 
 The drug Pachai Karpoorathi Chooranam has been selected and 
various studies carried out to find out its efficacy in the treatment of Gunmam. 
• Availability, preparation and preservation of the drug is easy and 
also economical. 
• The various studies clearly showed the antiulcer activity of the drug. 
• The clinical study proved that the drug was effective and good in 
73% of cases and showed moderate response in 23% of cases. 
• All the above studies and results lead to a fact that the formulation of 
"Pachai Karpoorathi Chooranam" can play a good role in 
Gunmam. 
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